Dirección de esta página: http://www.nlm.nih.gov/medlineplus/spanish/druginfo/natural/1003.html

Selenio

¿Qué es?

El selenio es un mineral. El cuerpo lo obtiene del agua y los alimentos. La gente lo usa como medicina.

La mayor parte del selenio que se encuentra en el cuerpo viene de la dieta. La cantidad de selenio que hay en los alimentos depende de donde se ha cultivado o criado. El cangrejo, el hígado, el pescado, las aves y el trigo son generalmente buenas fuentes de selenio. La cantidad de selenio en las tierras en las diferentes partes del mundo varía mucho, lo que significa que los alimentos cultivados en estas tierras tienen diferentes niveles de selenio. En los Estados Unidos, la Llanura Costera Oriental y el Noroeste del Pacífico tienen los niveles más bajos de selenio. La gente en esas regiones obtienen en la dieta alrededor de 60 a 90 mcg de selenio al día. A pesar de que esta cantidad de selenio es adecuada, está por debajo de la ingesta diaria promedio en los Estados Unidos, que es de 125 mcg.

El selenio se usa para las enfermedades del corazón y los vasos sanguíneos, incluyendo los derrames cerebrales y el "endurecimiento de las arterias" (arterioesclerosis). También se usa en la prevención de diferentes cánceres incluyendo el cáncer de la próstata, del estómago, del pulmón y de la piel.

Algunas personas usan selenio para la tiroides hipoactiva, la osteoartritis, la artritis reumática (AR), una enfermedad ocular llamada degeneración macular, la fiebre de heno, la infertilidad, las cataratas, las canas, los resultados anormales de la prueba de Papanicolaou, el síndrome de fatiga crónica (SFC), los trastornos del estado de ánimo, el envenenamiento por arsénico y para prevenir el aborto espontáneo.

El selenio se usa también para prevenir serias complicaciones y la muerte como resultado de enfermedades críticas tales como una lesión en la cabeza y quemaduras. También se usa en la prevención de la gripe aviar, el tratamiento del VIH/SIDA y para reducir los efectos secundarios de la quimioterapia para el cáncer.

¿Qué tan efectivo es?

Natural Medicines Comprehensive Database (La Base Exhaustiva de Datos de Medicamentos Naturales) clasifica la eficacia, basada en evidencia científica, de acuerdo a la siguiente escala: Eficaz, Probablemente Eficaz, Posiblemente Eficaz, Posiblemente Ineficaz, Probablemente Ineficaz, Ineficaz, e Insuficiente Evidencia para Hacer una Determinación.

La clasificación de la eficacia para este producto es la siguiente:

Probablemente eficaz para...

  • Carencia de selenio. La ingesta de selenio es efectiva para prevenir la carencia de selenio.

Posiblemente eficaz para...

  • La tiroiditis autoinmune (tiroides de Hashimoto). La investigación muestra que la ingesta de 200 mcg de selenio diarios junto con la hormona tiroidea podría disminuir la cantidad de anticuerpos en el cuerpo que contribuyen a esta enfermedad. El selenio podría también ayudar a mejorar el estado de ánimo y la sensación general de bienestar en las personas con esta condición.
  • Niveles anormales de colesterol. Algunas investigaciones demuestran que la ingesta de 100-200 mcg de un suplemento de selenio específico (SelenoPrecise, Pharma Nord, Denmark) durante 6 meses puede reducir modestamente los niveles de colesterol. Muchas personas en este estudio tenían niveles bajos de selenio en su cuerpo antes del comienzo del estudio. No está claro si tomar selenio extra tendría algún beneficio para los niveles de colesterol en personas con niveles normales de selenio en el cuerpo.

Posiblemente ineficaz para...

  • Asma. La investigación sugiere que no existe vínculo entre los niveles de selenio en sangre y el asma. Además, la investigación sugiere que la ingesta diaria de 100 mcg durante hasta 24 semanas no mejora la calidad de vida, la función pulmonar, los síntomas del asma o disminuye el uso del inhalador en personas con asma.
  • Eccema (dermatitis atópica). La investigación sugiere que la ingesta diaria de levadura enriquecida con 600 mcg de selenio durante 12 semanas, solo o junto con vitamina E, no mejora la gravedad del eccema.
  • Cardiopatía. La ingesta de 100 mcg de selenio junto con betacarteno, vitamina C y vitamina E no parece prevenir el empeoramiento de la cardiopatía. Además, la ingesta diaria de 200 mcg de selenio durante casi 8 años no reduce el riesgo de desarrollar cardiopatía.
  • Neurotoxicidad causada por medicamentos quimioterapéuticos. La investigación preliminar sugiere que la ingesta de vitaminas C y E junto con selenio no previene la neurotoxicidad o la pérdida de audición causada por el medicamento quimioterapéutico cisplastina.
  • Enfermedad grave (quemaduras, lesión y traumatismo). La administración de 500-1000 mcg de selenio por vía intravenosa (VI) o la ingesta diaria de 300 mg de selenio (ebselen) en personas muy enfermas no parece reducir el riesgo de muerte o infección.
  • Diabetes. Cierta investigación muestra que las personas con bajos niveles de selenio presentan un alto grado de probabilidad de desarrollar diabetes tipo 2. Sin embargo, otra investigación muestra que las personas con altos niveles de selenio también presentan un alto grado de desarrollar diabetes tipo 2. Además, la investigación más confiable muestra que las personas que ingieren por día 200 mcg de selenio durante aproximadamente 7,7 años presentan una alto grado de probabilidad de desarrollar diabetes tipo 2.
  • Hepatitis. La investigación muestra que la ingesta de 200 mcg de selenio junto con vitamina C y vitamina E durante seis meses no mejora la función hepática o los niveles del virus en personas con hepatitis C.
  • Infertilidad. La investigación sugiere que la ingesta diaria de 100-200 mcg de selenio de manera aislada o junto con vitamina A, vitamina C y vitamina E durante 3-4 meses, no mejora la función espermática en hombres infértiles.
  • Bajo peso al nacer. El suplemento diario de selenio, la ingesta diaria de 7 mcg/kg o 5 mcg/kg por vía intravenosa (VI), no parece mejorar la salud en loes bebes con bajo peso al nacer.
  • Cáncer de pulmón. Una mayor ingesta de selenio, ya sea solo o junto con vitamina E y betacaroteno, no parece disminuir el riesgo de desarrollar cáncer de pulmón, excepto posiblemente en personas con niveles de selenio relativamente bajos (carencia de selenio). Aún en este grupo, la disminución del riesgo es pequeña.
  • Cáncer de próstata. Existe mucho interés en investigar si la ingesta de selenio disminuye la probabilidad de desarrollar cáncer de próstata. Este interés se generó al observar que el cáncer de próstata parece ser menos común hombres con altos niveles de selenio en sus cuerpos. Hasta el momento, se han desarrollado grandes estudios científicos a largo plazo.
  • Enrojecimiento e irritación de la piel (psoriasis). La mayoría de la evidencia sugiere que el selenio no reduce la probabilidad de desarrollar cancer de próstata. La investigación sugiere que la ingesta diaria de levadura enriquecida con 600 mcg de selenio no reduce la gravedad de la psoriasis.
  • Cáncer de piel. La ingesta de 200 mcg de selenio no parece reducir el riesgo de desarrollar cierto tipo específico de cáncer de la piel llamado carcinoma de células basales. De hecho, cierta evidencia científica sugiere que el tomar selenio extra podría aumentar el riesgo de desarrollar otro tipo de cáncer de la piel llamado carcinoma de células escamosas.

Insuficiente evidencia para hacer una determinación para...

  • Enfermedad hepática relacionada con el alcohol. La investigación muestra que la ingesta diaria de 200 mcg de selenio junto con cinc y vitamina C puede reducir el tiempo de permanencia en el hospital y el riesgo de muerte en personas con enfermedad hepática relacionada con el alcohol.
  • Envenenamiento por arsénico. La levadura enriquecida con selenio parece disminuir la cantidad de arsénico absorbida por el cuerpo en chinos expuestos a altos niveles de arsénico en el ambiente.
  • Quemaduras. La investigación sugiere que la ingesta diaria de 315-380 mcg de selenio junto con cobre y cinc puede reducir el riesgo de neumonía en personas hospitalizadas pir quemaduras. Otra investigación sugiere que esta misma combinación podría reducir el tiempo de permanencia en el hospital, pero no el tiempo de cicatrización de las heridas.
  • Cáncer. Cierta investigación muestra que la ingesta diaria de 400 mcg de selenio durante dos años o 100 mcg de selenio junto con cinc, vitamina C, vitamina E y betacaroteno durante 7,5 años no reduce el riesgo de desarrollar cáncer. Sin embargo, otra investigación sugiere que la ingesta de selenio podría disminuir el riesgo de muerte relacionado con cáncer. Además, cuando se clasifica por género, cierta investigación muestra que el selenio podría disminuir el riesgo de cáncer solo en los hombres, mientras que el selenio junto con el allitridum podría disminuir el riesgo de cáncer solo en las mujeres.
  • Cáncer de colon y de recto. Es contradictoria la evidencia sobre el efecto del selenio para el tratamiento del cáncer de colon y de recto. Un estudio de población sugiere que los bajos niveles de selenio en la sangre no están vinculados con un mayor riesgo de desarrollar cáncer de colon y de recto. Cierta investigación sugiere que la ingesta de selenio, solo o junto con antioxidantes, podría disminuir el riesgo de cáncer de colon y de recto o úlceras precancerosas. No obstante, otra investigación sugiere que el selenio no tiene efecto.
  • Cáncer de esófago. La ingesta de suplementos de selenio no parece disminuir de riesgo de cáncer de esófago.
  • Cáncer de estómago. La ingesta de selenio junto con vitamina C y vitamina y vitamina E durante aproximadamente siete años no parece reducir el riesgo de desarrollar ulceras estomacales precancerosas.
  • VIH/SIDA. Hay resultados contradictorios sobre el efecto de los suplementos de selenio en el VIH. Cierta evidencia muestra que la ingesta diaria de selenio durante hasta un máximo de dos años puede disminuir la velocidad con la que el VIH se disemina y puede disminuir la función inmunitaria. No obstante, otra investigación sugiere que el selenio no tiene efecto.
  • Niveles bajos de hormona tiroidea (hipotiroidismo). Cierta investigación muestra que la ingesta de ácido fólico podría mejorar la función mental en personas en edad avanzada. No obstante, otra investigación sugiere que el selenio no tiene efecto. La ingesta de selenio puede empeorar el hipotiroidismo en personas con carencia de iodo.
  • Accidente cerebrovascular (ACV). Cierta investigación sugiere que administrar selenio (ebselen) dentro de las 24 horas de ocurrido un ACV mejora la recuperación.
  • Enfermedad en los huesos y las articulaciones (enfermedad de Kashin-Beck). El selenio no parece mejorar el dolor y movimiento en las articulaciones en niños con la enfermedad de Kashin-Beck.
  • Cáncer de hígado. Investigación preliminar realizada en China sugiere que la ingesta de selenio durante 2-5 años puede reducir la aparición de cáncer de hígado. No es clara la información de si el selenio podría disminuir el riesgo de cáncer de hígado en países occidentales.
  • Distrofia muscular. La investigación preliminar sugiere que la ingesta diaria de una solución de selenio soluble en agua durante seis meses no resulta beneficia para las personas con distrofia muscular.
  • Artritis (osteoartritis). Los niveles bajos de selenio parecen estar vinculados con un riesgo mayor de desarrollar osteoartritis. Sin embargo, no se sabe si los suplementos de selenio pueden prevenir la osteoartritis.
  • Cáncer de ovario. La investigación sugiere que no existe vínculo entre el consumo de selenio en la dieta y el riego de desarrollar cáncer de ovario.
  • Riesgo general de muerte. Cierta investigación sugiere que la ingesta diaria de 100 mcg de selenio junto con cinc, vitamina C, vitamina E y betacaroteno durante 7,5 años podría reducir el riesgo de muerte por cualquier causa en hombres, pero no en mujeres. Otra investigación sugiere que selenio, solo o junto con otros nutrientes, no disminuye el riesgo de muerte.
  • Pancreatitis. Es contradictoria la evidencia sobre el efecto del selenio para el tratamiento de la pancreatitis. Cierta investigación sugiere que el selenio no tiene efecto. Sin embargo, otra investigación sugiere que la ingesta diaria de una solución de selenio soluble en agua podría reducir el riesgo de muerte causado por pancreatitis grave.
  • Inflamación en brazos y piernas después de una cirugía. La evidencia preliminar sugiere que la ingesta de suplementos de selenio durante 15 semanas podría prevenir las infecciones bacterianas de piel en mujeres con inflamación en brazos y piernas después de una cirugía por cáncer de mama.
  • Hipertensión arterial durante el embarazo. La investigación sugiere que la ingesta diaria de 100 mcg de selenio líquido durante 6-8 semanas durante el embarazo puede reducir la aparición de la presión arterial alta.
  • Destrucción de las vías biliares del hígado (cirrosis biliar primaria). La ingesta de selenio con vitamina A, vitamina C metionina y coenzima Q10 durante 12 semanas no parece mejorar la fatiga u otros síntomas en personas con cirrosis biliar primaria.
  • Artritis reumatoide (AR). Es inconsistente la evidencia sobre la efectividad del selenio para tratar la artritis reumatoide. Cierta investigación sugiere que la ingesta de levadura enriquecida con 200 mcg de selenio no mejora la AR. Sin embargo, otra investigación sugiere que la ingesta diaria de 200 mcg de selenio líquido durante 3 meses reduce la inflamación de las articulaciones, la sensibilidad y la rigidez en personas con AR.
  • Septicemia. Cierta investigación sugiere que administrar selenio solo o junto con antioxidantes podría disminuir el riesgo de muerte causado por septicemia grave. Sin embargo, otra investigación sugiere que administrar selenio con L-arginina, ácidos grasos omega 3, vitamina E, betacaroteno y cinc podría incrementar el riesgo de muerte en personas con septicemia.
  • Enfermedad inflamatoria intestinal (colitis ulcerosa). La investigación preliminar sugiere que la ingesta de selenio con aceite de pescado, endulzantes naturales, goma arábica, vitamina E y vitamina C no resulta beneficioso en personas con una enfermedad inflamatoria intestinal, llamada colitis ulcerosa. Sin embargo, la ingesta de esta misma combinación no parece mejorar la necesidad de recurrir a los medicamentos.
  • Arterioesclerosis.
  • Degeneración macular (enfermedad ocular).
  • Fiebre del heno.
  • Cana.
  • Efectos secundarios de la quimioterapia.
  • Resultados anormales de la prueba de Papanicolao.
  • Catarata.
  • Síndrome de fatiga crónica (SFC).
  • Gripe aviar.
  • Prevención de un aborto espontáneo.
  • El riesgo de cáncer en general.
  • Otras afecciones.
Se necesita más evidencia para evaluar el selenio para estos usos.

¿Cómo funciona?

El selenio es importante para el buen funcionamiento de muchos procesos en el cuerpo. Parece aumentar la acción de los antioxidantes.

¿Hay preocupación por la seguridad de su uso?

El selenio PROBABLEMENTE ES SEGURO para la mayoría de la gente cuando se toma por vía oral en dosis menores de 400 mcg por día y a corto plazo.

El selenio NO ES POSIBLEMENTE SEGURO cuando se ingieren en grandes cantidades durante tiempo prolongado. La ingesta de dosis mayores a 400 mcg puede incrementar el riesgo de desarrollar toxicidad el selenio. La ingesta de bajas dosis durante largo tiempo puede incrementar el riesgo de desarrollar diabetes. Las altas dosis de selenio pueden producir efectos secundarios significativos que incluyen náuseas, vómitos, cambios en las uñas, irritabilidad y pérdida de energía. El envenenamiento debido al uso a largo plazo es parecido al envenenamiento por arsénico, con síntomas que incluyen pérdida de cabello, rayas blancas en las uñas, inflamación de las uñas, fatiga, irritabilidad, náusea, vómitos, aliento con olor a ajo y sabor metálico en la boca.

El selenio puede también causar sensibilidad en los senos, temblores, mareos, enrojecimiento en la cara, problemas de coagulación, problemas hepáticos y renales y otros efectos secundarios.

Advertencias y precauciones especiales:

Niños: El selenio es PROBABLEMENTE SEGURO cuando se lo ingiere de manera apropiada. El selenio parece ser seguro cuando se lo usa en dosis diarias menores a 45 mcg durante breve tiempo en bebés hasta los seis meses, dosis diarias de 60 mcg en bebés de los siete a los 12 meses, dosis diarias de 90 mcg en niños de uno a tres años, dosis diarias de 150 mcg en niños de 4 a 8 años, dosis diarias de 280 mcg en niños de 9 a 13 años y dosis diarias de 400 mcg en niños de 14 años o mayores.

Embarazo y lactancia: El uso de selenio ES POSIBLEMENTE SEGURO durante el embarazo y la lactancia cuando se lo ingieren en cantidades comúnmente presentes en los alimentos. El selenio NO ES POSIBLEMENTE SEGURO durante el embarazo y la lactancia cuando se ingieren dosis diarias mayores a 400 mcg, dado que podría ser tóxico.

Enfermedades autoinmunitarias: El selenio podría estimular el sistema inmunitario. En teoría, el selenio podría empeorar el desarrollo de las enfermedades autoinmunitarias dado que podría estimular la actividad de la enfermedad. Las personas con enfermedades autoinmunitarias como la esclerosis múltiple, el lupus eritematoso diseminado (LED), la artritis reumatoide (AR) entre otras deberías evitar la ingesta de selenio.

Hemodiálisis: Los niveles de selenio en la sangre pueden ser más bajos en las personas sometidas a hemodiálisis. El uso de una solución con selenio para diálisis podría aumentar los niveles de selenio, sin embargo el suplemento de selenio podría ser beneficioso para ciertas personas.

Problemas de fertilidad en los hombres: El selenio podría disminuir la motilidad de los espermatozoides, lo que podría disminuir la fertilidad. No tome suplementos de selenio si está tratando de engendrar un hijo.

Cáncer a la piel: El uso de suplementos de selenio podría aumentar levemente el riesgo de recurrencia de cáncer a la piel, pero esto es discutible. Hasta que no se tenga más información acerca del posible aumento del riesgo de cáncer a la piel, evite consumir suplementos de selenio si alguna vez ha tenido cáncer de la piel.

Baja actividad de la tiroides (hipotiroidismo): El tomar selenio puede empeorar el hipotiroidismo especialmente en las personas que tienen deficiencia de iodo. En ese caso, debe tomar iodo junto con selenio. Converse con su proveedor de atención médica.

Cirugía: El selenio puede aumentar el riesgo de sangrado durante o después de la cirugía. Deje de tomar selenio por lo menos dos semanas antes de una cirugía programada.

¿Existen interacciones con medicamentos?

Moderadas
Tenga cuidado con esta combinación
Medicamentos que debilitan el sistema inmunitario (Inmunosupresores)
El selenio podría estimular el sistema inmunitario. Al estimular el sistema inmunitario, el selenio podría disminuir la efectividad de los medicamentos que debilitan el sistema inmunitario.

Algunos medicamentos que debilitan el sistema inmunitario incluyen azatioprina (Imuran), basiliximab (Simulect), ciclosporina (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), micofenolato (CellCept), tacrolimus (FK506, Prograf), sirolimus (Rapamune), prednisona (Deltasone, Orasone) y otros corticoesteroides (glucocorticoides).
Medicamentos que retardan la coagulación sanguínea (Medicamentos anticoagulantes / antiplaquetarios)
El selenio podría retardar la coagulación sanguínea. El tomar selenio junto con medicamentos que también retardan la coagulación podría aumentar la posibilidad de sufrir hematomas y pérdida de sangre.

Algunos de los medicamentos que retardan la coagulación sanguínea incluyen aspirina, clopidogrel (Plavix), dalteparin (Fragmin), enoxaparin (Lovenox), heparina, ticlopidina (Ticlid), warfarina (Coumadin) y otros.
Medicamentos que se usan para bajar el colesterol (Estatinas)
El tomar selenio, betacaroteno, vitamina C y vitamina E juntos podría disminuir la eficacia de algunos medicamentos que se usan para bajar el colesterol. No se sabe si el selenio, si se toma solo, disminuye la eficacia de algunos medicamentos que se usan para bajar el colesterol.

Algunos medicamentos que se usan para bajar el colesterol incluyen a atorvastatina (Lipitor), fluvastatina (Lescol), lovastatina (Mevacor) y pravastatina (Pravachol).
Medicamentos sedantes (Barbituratos)
El cuerpo humano descompone los medicamentos para eliminarlos. El selenio puede disminuir la rapidez con que el cuerpo descompone los medicamentos sedantes (Barbituratos). El tomar selenio con estos medicamentos podría aumentar los efectos y efectos secundarios de estos medicamentos.
Niacina
El tomar selenio, betacaroteno, vitamina C y vitamina E juntos podría disminuir algunos de los efectos beneficiosos de la niacina. La niacina puede aumentar el colesterol bueno. El tomar selenio juntos con estas otras vitaminas podría afectar el buen efecto que tiene la niacina para aumentar el colesterol bueno.
Warfarina
El selenio podría adelgazar la sangre. El selenio podría también aumentar los efectos de la warfarina en el cuerpo. El tomar selenio junto con warfarina podría aumentar la posibilidad de sufrir hematomas y pérdida de sangre.
Menores
Preste atención a esta combinación
Píldoras anticonceptivas
Algunas investigaciones muestran que las mujeres que toman píldoras anticonceptivas podrían tener niveles altos de selenio en la sangre. Pero otras investigaciones no muestran cambio en los niveles de selenio en las mujeres que toman píldoras anticonceptivas. No hay suficiente información para saber si hay una interacción importante entre las píldoras anticonceptivas y el selenio.

Algunas de las píldoras anticonceptivas incluyen etinil estradiol y levonorgestrel (Triphasil), etinil estradiol y noretindrona (Ortho-Novum 1/35, Ortho-Novum 7/7/7) y otras.
Sales de oro
Las sales de oro se unen al selenio y disminuyen el selenio en ciertas partes del cuerpo. Esto podría disminuir la actividad normal del selenio, lo que posiblemente podría producir síntomas de deficiencia de selenio.

Las sales de oro incluyen a aurotioglucosa (Solganol), tiomalato de oro y sodio (Aurolate) y auranofina (Ridaura).

¿Existen interacciones con hierbas y suplementos?

Ácidos grasos omega 3
La ingesta de selenio con ácidos grasos omega 3 podría reducir la cantidad de selenio absorbida por el cuerpo.
Astragalo
Algunas de las especies de astrágalo acumulan grandes cantidades de selenio, especialmente cuando se cultivan en tierras ricas en selenio. El tomar productos hechos de estas plantas junto con suplementos de selenio podría producir envenenamiento por selenio. Sin embargo, la mayoría de los suplementos de astrágalo contienen astrágalo chino el cual no es un acumulador de selenio.
Cobre
El selenio podría mejorar la rapidez con que el cuerpo elimina el cobre. En teoría, la ingesta de selenio podría reducir los niveles de cobre en el cuerpo.
Hierbas y suplementos que podrían disminuir la coagulación de la sangre
La ingesta de selenio junto con otras hierbas que pueden disminuir la coagulación de la sangre podría aumentar el riesgo de sufrir hemorragia en algunas personas. Estas hierbas incluyen angélica, clavo de olor, danshen, ajo, jengibre, ginkgo, ginseng Panax ginseng entre otros.
Vitamina C
La ingesta de vitamina C podría modificar la cantidad de selenio absorbida por el cuerpo. Sin embargo, no es probable que exista una interacción importante debido a este uso.
Zinc
El zinc podría hacer más difícil la absorción de selenio de los alimentos.

¿Existen interacciones con alimentos?

No se conoce ninguna interacción con alimentos.

¿Qué dosis se utiliza?

Las siguientes dosis han sido estudiadas en investigaciones científicas:

POR VÍA ORAL:

  • Tiroiditis autoinmune (tiroiditis de Hashimoto): 200 mcg diarios.
  • Colesterol alto: 100-200 mcg al día de un producto específico de selenio (SelenoPrecise, Pharma Nord, Denmark).
La ingesta diaria recomendada (RDA) de selenio es:
  • Para los niños de 1-3 años: 20 mcg; niños de 4-8 años: 30 mcg; niños de 9-13 años: 40 mcg;
  • Para mayores de 13 años: 55 mcg;
  • Para las mujeres embarazadas: 60 mcg; Para las mujeres amamantando: 70 mcg. Debido a la demanda del feto en la madre, la cantidad de selenio necesaria durante el embarazo es mayor.
  • La ingesta diaria recomendada para los infantes no ha sido determinada. Para los infantes de hasta 6 meses la ingesta adecuada (AI) es de 2,1 mcg/kg al día . Para los infantes de 7-12 meses: 2,2 mcg/kg al día.
La dosis máxima tolerable es:
  • Para adultos y adolescentes mayores de 14 años 400 mcg/día.
  • La ingesta máxima tolerable (UL) para infantes de hasta 6 meses: 45 mcg/día;
  • Para infantes de 7-12 meses: 60 mcg por día;
  • Para niños de 1-3 años: 90 mcg por día;
  • Para niños de 4-8 años: 150 mcg por día;
  • Para niños de 9-13 años: 280 mcg por día.

Otros nombres

Atomic number 34, Dioxyde de Sélénium, Ebselen, L-Selenomethionine, L-Sélénométhionine, Levure Sélénisée, Numéro Atomique 34, Se, Selenite, Sélénite de Sodium, Sélénium, Selenium Ascorbate, Selenium Dioxide, Selenized Yeast, Selenomethionine, Sélénométhionine, Sodium Selenite.

Metodología

Para saber más sobre cómo este artículo fue escrito, refiérase a la metodología de la Base exhaustiva de datos de medicamentos naturales.

Referencias

  1. Bonelli, L., Camoriano, A., Ravelli, P., Missale, G., Bruzzi, P., and Aste, H. Reduction of the incidence of metachronous adenomas of the large bowel by means of antioxidants. Proceedings of International Selenium Tellurium Development Association 1998;91-94.
  2. Srivastava, K. C. Ascorbic acid enhances the formation of prostaglandin E1 in washed human platelets and prostacyclin in rat aortic rings. Prostaglandins Leukot Med 1985;18:227-233.
  3. Stevic, Z., Nicolic, A., and Blagojevic, D. A controlled trial of combination of methionine and antioxidants in ALS patients. Jugoslovenska Medicinska Biohemija 2011;20:223-228.
  4. Zima, T., Mestek, O., Nemecek, K., Bartova, V., Fialova, J., Tesar, V., and Suchanek, M. Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif. 1998;16:253-260. View abstract.
  5. Liu, X., Yin, S., and Li, G. [Effects of selenium supplement on acute lower respiratory tract infection caused by respiratory syncytial virus]. Zhonghua Yu Fang Yi.Xue.Za Zhi. 1997;31:358-361. View abstract.
  6. Apostolski, S., Marinkovic, Z., Nikolic, A., Blagojevic, D., Spasic, M. B., and Michelson, A. M. Glutathione peroxidase in amyotrophic lateral sclerosis: the effects of selenium supplementation. J Environ.Pathol.Toxicol.Oncol. 1998;17(3-4):325-329. View abstract.
  7. Sieja, K. Selenium (Se) deficiency in women with ovarian cancer undergoing chemotherapy and the influence of supplementation with this micro-element on biochemical parameters. Pharmazie 1998;53:473-476. View abstract.
  8. Bogye, G., Alfthan, G., and Machay, T. Randomized clinical trial of enteral yeast-selenium supplementation in preterm infants. Biofactors 1998;8(1-2):139-142. View abstract.
  9. Scott, R., MacPherson, A., Yates, R. W., Hussain, B., and Dixon, J. The effect of oral selenium supplementation on human sperm motility. Br.J Urol. 1998;82:76-80. View abstract.
  10. Gail, M. H., You, W. C., Chang, Y. S., Zhang, L., Blot, W. J., Brown, L. M., Groves, F. D., Heinrich, J. P., Hu, J., Jin, M. L., Li, J. Y., Liu, W. D., Ma, J. L., Mark, S. D., Rabkin, C. S., Fraumeni, J. F., Jr., and Xu, G. W. Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data. Control Clin.Trials 1998;19:352-369. View abstract.
  11. Pakdaman, A. Symptomatic treatment of brain tumor patients with sodium selenite, oxygen, and other supportive measures. Biol.Trace Elem.Res. 1998;62(1-2):1-6. View abstract.
  12. Persson-Moschos, M., Alfthan, G., and Akesson, B. Plasma selenoprotein P levels of healthy males in different selenium status after oral supplementation with different forms of selenium. Eur.J Clin.Nutr. 1998;52:363-367. View abstract.
  13. Saito, I., Asano, T., Sano, K., Takakura, K., Abe, H., Yoshimoto, T., Kikuchi, H., Ohta, T., and Ishibashi, S. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 1998;42:269-277. View abstract.
  14. Favier, M. and Hininger, I. [Trace elements: zinc, copper, selenium, chromium. Consequences of a deficiency, of excessive trace elements, and value of systematic supplementation]. J Gynecol.Obstet.Biol.Reprod.(Paris) 1997;26(3 Suppl):109-114. View abstract.
  15. Yamaguchi, T., Sano, K., Takakura, K., Saito, I., Shinohara, Y., Asano, T., and Yasuhara, H. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke 1998;29:12-17. View abstract.
  16. Galan, P., Preziosi, P., Monget, A. L., Richard, M. J., Arnaud, J., Lesourd, B., Girodon, F., Alferez, M. J., Bourgeois, C., Keller, H., Favier, A., and Hercberg, S. Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX. Int J Vitam.Nutr.Res. 1997;67:450-460. View abstract.
  17. Johnson, M. A. and Porter, K. H. Micronutrient supplementation and infection in institutionalized elders. Nutr Rev. 1997;55(11 Pt 1):400-404. View abstract.
  18. Zimmermann, T., Albrecht, S., Kuhne, H., Vogelsang, U., Grutzmann, R., and Kopprasch, S. [Selenium administration in patients with sepsis syndrome. A prospective randomized study]. Med Klin 9-15-1997;92 Suppl 3:3-4. View abstract.
  19. Heinle, K., Adam, A., Gradl, M., Wiseman, M., and Adam, O. [Selenium concentration in erythrocytes of patients with rheumatoid arthritis. Clinical and laboratory chemistry infection markers during administration of selenium]. Med Klin 9-15-1997;92 Suppl 3:29-31. View abstract.
  20. Powis, G., Gasdaska, J. R., Gasdaska, P. Y., Berggren, M., Kirkpatrick, D. L., Engman, L., Cotgreave, I. A., Angulo, M., and Baker, A. Selenium and the thioredoxin redox system: effects on cell growth and death. Oncol.Res. 1997;9(6-7):303-312. View abstract.
  21. Meltzer, H. M., Folmer, M., Wang, S., Lie, O., Maage, A., Mundal, H. H., and Ydersbond, T. A. Supplementary selenium influences the response to fatty acid-induced oxidative stress in humans. Biol Trace Elem Res 1997;60(1-2):51-68. View abstract.
  22. Combs, G. F., Jr., Clark, L. C., and Turnbull, B. W. Reduction of cancer mortality and incidence by selenium supplementation. Med Klin 9-15-1997;92 Suppl 3:42-45. View abstract.
  23. Xu, G. L., Wang, S. C., Gu, B. Q., Yang, Y. X., Song, H. B., Xue, W. L., Liang, W. S., and Zhang, P. Y. Further investigation on the role of selenium deficiency in the aetiology and pathogenesis of Keshan disease. Biomed.Environ.Sci 1997;10(2-3):316-326. View abstract.
  24. Combs, G. F., Jr., Clark, L. C., and Turnbull, B. W. Reduction of cancer risk with an oral supplement of selenium. Biomed.Environ Sci 1997;10(2-3):227-234. View abstract.
  25. Gasmi, A., Garnier, R., Galliot-Guilley, M., Gaudillat, C., Quartenoud, B., Buisine, A., and Djebbar, D. Acute selenium poisoning. Vet Hum Toxicol 1997;39:304-308. View abstract.
  26. Engel, J. M., Menges, T., Neuhauser, C., Schaefer, B., and Hempelmann, G. [Effects of various feeding regimens in multiple trauma patients on septic complications and immune parameters]. Anasthesiol.Intensivmed.Notfallmed.Schmerzther. 1997;32:234-239. View abstract.
  27. Girodon, F., Blache, D., Monget, A. L., Lombart, M., Brunet-Lecompte, P., Arnaud, J., Richard, M. J., and Galan, P. Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters. J Am.Coll.Nutr. 1997;16:357-365. View abstract.
  28. Hathcock, J. N. Vitamins and minerals: efficacy and safety. Am.J Clin.Nutr. 1997;66:427-437. View abstract.
  29. Margaritis, I., Tessier, F., Prou, E., Marconnet, P., and Marini, J. F. Effects of endurance training on skeletal muscle oxidative capacities with and without selenium supplementation. J Trace Elem.Med Biol. 1997;11:37-43. View abstract.
  30. Zamora, A. J., Tessier, F., Marconnet, P., Margaritis, I., and Marini, J. F. Mitochondria changes in human muscle after prolonged exercise, endurance training and selenium supplementation. Eur.J Appl.Physiol Occup.Physiol 1995;71:505-511. View abstract.
  31. Monget, A. L., Richard, M. J., Cournot, M. P., Arnaud, J., Galan, P., Preziosi, P., Herbeth, B., Favier, A., and Hercberg, S. Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network. Eur.J Clin.Nutr. 1996;50:443-449. View abstract.
  32. Tortajada, J., Lopez Andreu, J. A., Benedito Monleon, M. C., and Castell, J. [The pediatrician and cancer prevention. Dietetic factors and smoking]. An.Esp.Pediatr. 1996;45:6-13. View abstract.
  33. Yagi, M., Tani, T., Hashimoto, T., Shimizu, K., Nagakawa, T., Miwa, K., and Miyazaki, I. Four cases of selenium deficiency in postoperative long-term enteral nutrition. Nutrition 1996;12:40-43. View abstract.
  34. Neve, J. Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity. J Trace Elem Med Biol 1995;9:65-73. View abstract.
  35. Badmaev, V., Majeed, M., and Passwater, R. A. Selenium: a quest for better understanding. Altern.Ther Health Med 1996;2:59-7. View abstract.
  36. Daniels, L., Gibson, R., and Simmer, K. Randomised clinical trial of parenteral selenium supplementation in preterm infants. Arch Dis Child Fetal Neonatal Ed 1996;74:F158-F164. View abstract.
  37. Mi, Y. Y., Hu, Y. J., and Zhou, M. Z. [Study of relationship between level of serum selenium and syndrome differentiation and typing of traditional Chinese medicine in lung cancer]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1995;15:658-660. View abstract.
  38. Bogye, G. and Tompos, G. [Endemic iodine deficiency in Hungary and possibilities of iodine substitution]. Orv.Hetil. 2-11-1996;137:287-290. View abstract.
  39. Delmas-Beauvieux, M. C., Peuchant, E., Couchouron, A., Constans, J., Sergeant, C., Simonoff, M., Pellegrin, J. L., Leng, B., Conri, C., and Clerc, M. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene. Am.J Clin.Nutr. 1996;64:101-107. View abstract.
  40. Srivastava, A. K., Gupta, B. N., Bihari, V., and Gaur, J. S. Generalized hair loss and selenium exposure. Vet.Hum.Toxicol. 1995;37:468-469. View abstract.
  41. Rannem, T., Ladefoged, K., Hylander, E., Christiansen, J., Laursen, H., Kristensen, J. H., Linstow, M., Beyer, N., Liguori, R., Dige-Petersen, H., and . The effect of selenium supplementation on skeletal and cardiac muscle in selenium-depleted patients. JPEN J Parenter.Enteral Nutr. 1995;19:351-355. View abstract.
  42. Iwanier, K. and Zachara, B. A. Selenium supplementation enhances the element concentration in blood and seminal fluid but does not change the spermatozoal quality characteristics in subfertile men. J Androl 1995;16:441-447. View abstract.
  43. Bonomini, M., Forster, S., De Risio, F., Rychly, J., Nebe, B., Manfrini, V., Klinkmann, H., and Albertazzi, A. Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis. Nephrol Dial.Transplant 1995;10:1654-1661. View abstract.
  44. Celerier, P., Richard, A., Litoux, P., and Dreno, B. Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines. Arch.Dermatol.Res. 1995;287:680-682. View abstract.
  45. Hasselmark, L., Malmgren, R., Zetterstrom, O., and Unge, G. Selenium supplementation in intrinsic asthma. Allergy 1993;48:30-36. View abstract.
  46. Marcus, R. W. Myopathy and cardiomyopathy associated with selenium deficiency: case report, literature review, and hypothesis. Md Med J 1993;42:669-674. View abstract.
  47. Levy, J. B., Jones, H. W., and Gordon, A. C. Selenium deficiency, reversible cardiomyopathy and short-term intravenous feeding. Postgrad.Med J 1994;70:235-236. View abstract.
  48. Bunker, V. W., Stansfield, M. F., Deacon-Smith, R., Marzil, R. A., Hounslow, A., and Clayton, B. E. Dietary supplementation and immunocompetence in housebound elderly subjects. Br.J Biomed.Sci 1994;51:128-135. View abstract.
  49. Nyyssonen, K., Porkkala, E., Salonen, R., Korpela, H., and Salonen, J. T. Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial. Eur.J Clin Nutr 1994;48:633-642. View abstract.
  50. Berger, M. M., Cavadini, C., Chiolero, R., Guinchard, S., Krupp, S., and Dirren, H. Influence of large intakes of trace elements on recovery after major burns. Nutrition 1994;10:327-334. View abstract.
  51. Mundal, H. H., Meltzer, H. M., and Aursnes, I. Bleeding times related to serum triglyceride levels in healthy young adults. Thromb.Res. 8-1-1994;75:285-291. View abstract.
  52. Kiremidjian-Schumacher, L., Roy, M., Wishe, H. I., Cohen, M. W., and Stotzky, G. Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol.Trace Elem.Res. 1994;41(1-2):115-127. View abstract.
  53. Roy, M., Kiremidjian-Schumacher, L., Wishe, H. I., Cohen, M. W., and Stotzky, G. Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression. Biol.Trace Elem.Res. 1994;41(1-2):103-114. View abstract.
  54. Han, L. and Zhou, S. M. Selenium supplement in the prevention of pregnancy induced hypertension. Chin Med J (Engl) 1994;107:870-871. View abstract.
  55. Tessier, F., Hida, H., Favier, A., and Marconnet, P. Muscle GSH-Px activity after prolonged exercise, training, and selenium supplementation. Biol.Trace Elem.Res. 1995;47(1-3):279-285. View abstract.
  56. Van, Gossum A. and Neve, J. Low selenium status in alcoholic cirrhosis is correlated with aminopyrine breath test. Preliminary effects of selenium supplementation. Biol.Trace Elem.Res. 1995;47(1-3):201-207. View abstract.
  57. Portal, B., Richard, M. J., Coudray, C., Arnaud, J., and Favier, A. Effect of double-blind cross-over selenium supplementation on lipid peroxidation markers in cystic fibrosis patients. Clin.Chim.Acta 1-31-1995;234(1-2):137-146. View abstract.
  58. Kelloff, G. J., Boone, C. W., Steele, V. E., Fay, J. R., Lubet, R. A., Crowell, J. A., and Sigman, C. C. Mechanistic considerations in chemopreventive drug development. J Cell Biochem.Suppl 1994;20:1-24. View abstract.
  59. Meltzer, H. M. and Haug, E. Oral intake of selenium has no effect on the serum concentrations of growth hormone, insulin-like growth factor-1, insulin-like growth factor-binding proteins 1 and 3 in healthy women. Eur J Clin Chem Clin Biochem 1995;33:411-415. View abstract.
  60. Collipp, P. J. and Chen, S. Y. Cardiomyopathy and selenium deficiency in a two-year-old girl. N.Engl.J Med 5-21-1981;304:1304-1305. View abstract.
  61. Robinson, M. F., Campbell, D. R., Stewart, R. D., Rea, H. M., Thomson, C. D., Snow, P. G., and Squires, I. H. Effect of daily supplements of selenium on patients with muscular complaints in Otago and Canterbury. N.Z.Med J 5-13-1981;93:289-292. View abstract.
  62. Wilber, C. G. Toxicology of selenium: a review. Clin Toxicol. 1980;17:171-230. View abstract.
  63. Orndahl, G., Rindby, A., and Selin, E. Selenium therapy of myotonic dystrophy. Acta Med Scand. 1983;213:237-239. View abstract.
  64. Fleming, C. R., Lie, J. T., McCall, J. T., O'Brien, J. F., Baillie, E. E., and Thistle, J. L. Selenium deficiency and fatal cardiomyopathy in a patient on home parenteral nutrition. Gastroenterology 1982;83:689-693. View abstract.
  65. Quercia, R. A., Korn, S., O'Neill, D., Dougherty, J. E., Ludwig, M., Schweizer, R., and Sigman, R. Selenium deficiency and fatal cardiomyopathy in a patient receiving long-term home parenteral nutrition. Clin.Pharm 1984;3:531-535. View abstract.
  66. Kien, C. L. and Ganther, H. E. Manifestations of chronic selenium deficiency in a child receiving total parenteral nutrition. Am J Clin Nutr 1983;37:319-328. View abstract.
  67. Aberg, B. [Selenium as a trace element]. Nord.Med 5-26-1966;75:589-593. View abstract.
  68. Kumpulainen, J., Salmenpera, L., Siimes, M. A., Koivistoinen, P., and Perheentupa, J. Selenium status of exclusively breast-fed infants as influenced by maternal organic or inorganic selenium supplementation. Am.J Clin.Nutr. 1985;42:829-835. View abstract.
  69. Pentel, P., Fletcher, D., and Jentzen, J. Fatal acute selenium toxicity. J Forensic Sci 1985;30:556-562. View abstract.
  70. Dworkin, B., Newman, L. J., Berezin, S., Rosenthal, W. S., Schwarz, S. M., and Weiss, L. Low blood selenium levels in patients with cystic fibrosis compared to controls and healthy adults. JPEN J Parenter.Enteral Nutr. 1987;11:38-41. View abstract.
  71. Orndahl, G., Sellden, U., Hallin, S., Wetterqvist, H., Rindby, A., and Selin, E. Myotonic dystrophy treated with selenium and vitamin E. Acta Med Scand 1986;219:407-414. View abstract.
  72. Neve, J., Vertongen, F., and Capel, P. Selenium supplementation in healthy Belgian adults: response in platelet glutathione peroxidase activity and other blood indices. Am.J Clin.Nutr. 1988;48:139-143. View abstract.
  73. Gamstorp, I., Gustavson, K. H., Hellstrom, O., and Nordgren, B. A trial of selenium and vitamin E in boys with muscular dystrophy. J Child Neurol 1986;1:211-214. View abstract.
  74. Backman, E., Nylander, E., Johansson, I., Henriksson, K. G., and Tagesson, C. Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function. Acta Neurol Scand 1988;78:429-435. View abstract.
  75. Fairris, G. M., Lloyd, B., Hinks, L., Perkins, P. J., and Clayton, B. E. The effect of supplementation with selenium and vitamin E in psoriasis. Ann Clin Biochem 1989;26 ( Pt 1):83-88. View abstract.
  76. Korpela, H., Kumpulainen, J., Jussila, E., Kemila, S., Kaariainen, M., Kaariainen, T., and Sotaniemi, E. A. Effect of selenium supplementation after acute myocardial infarction. Res.Commun.Chem.Pathol.Pharmacol. 1989;65:249-252. View abstract.
  77. Holness, D. L., Taraschuk, I. G., and Nethercott, J. R. Health status of copper refinery workers with specific reference to selenium exposure. Arch.Environ.Health 1989;44:291-297. View abstract.
  78. Reeves, W. C., Marcuard, S. P., Willis, S. E., and Movahed, A. Reversible cardiomyopathy due to selenium deficiency. JPEN J Parenter.Enteral Nutr 1989;13:663-665. View abstract.
  79. Fairris, G. M., Perkins, P. J., Lloyd, B., Hinks, L., and Clayton, B. E. The effect on atopic dermatitis of supplementation with selenium and vitamin E. Acta Derm.Venereol. 1989;69:359-362. View abstract.
  80. Jackson, M. J., Coakley, J., Stokes, M., Edwards, R. H., and Oster, O. Selenium metabolism and supplementation in patients with muscular dystrophy. Neurology 1989;39:655-659. View abstract.
  81. Mutanen, M., Viita, L., and Mykkanen, H. M. Selenium supplementation does not alter platelet activation in subjects with normal selenium status. Int J Vitam.Nutr.Res. 1989;59:309-313. View abstract.
  82. Clausen, J., Nielsen, S. A., and Kristensen, M. Biochemical and clinical effects of an antioxidative supplementation of geriatric patients. A double blind study. Biol.Trace Elem.Res. 1989;20(1-2):135-151. View abstract.
  83. Meltzer, H. M., Norheim, G., Bibow, K., Myhre, K., and Holm, H. The form of selenium determines the response to supplementation in a selenium replete population. Eur.J Clin.Nutr. 1990;44:435-446. View abstract.
  84. Hommeren, O. J. [A comparative study of absorption of 2 organic selenium preparations and a placebo]. Tidsskr.Nor Laegeforen. 10-30-1990;110:3350-3351. View abstract.
  85. Fan, A. M. and Kizer, K. W. Selenium. Nutritional, toxicologic, and clinical aspects. West J Med 1990;153:160-167. View abstract.
  86. Hill, J. and Bird, H. A. Failure of selenium-ace to improve osteoarthritis. Br.J Rheumatol. 1990;29:211-213. View abstract.
  87. Backman, E. and Henriksson, K. G. Effect of sodium selenite and vitamin E treatment in myotonic dystrophy. J Intern.Med 1990;228:577-581. View abstract.
  88. Lockitch, G., Taylor, G. P., Wong, L. T., Davidson, A. G., Dison, P. J., Riddell, D., and Massing, B. Cardiomyopathy associated with nonendemic selenium deficiency in a Caucasian adolescent. Am.J Clin.Nutr. 1990;52:572-577. View abstract.
  89. Benton, D. and Cook, R. Selenium supplementation improves mood in a double-blind crossover trial. Psychopharmacology (Berl) 1990;102:549-550. View abstract.
  90. Peretz, A., Neve, J., Desmedt, J., Duchateau, J., Dramaix, M., and Famaey, J. P. Lymphocyte response is enhanced by supplementation of elderly subjects with selenium-enriched yeast. Am.J Clin.Nutr. 1991;53:1323-1328. View abstract.
  91. Butler, J. A., Thomson, C. D., Whanger, P. D., and Robinson, M. F. Selenium distribution in blood fractions of New Zealand women taking organic or inorganic selenium. Am.J Clin.Nutr. 1991;53:748-754. View abstract.
  92. Huston, R. K., Jelen, B. J., and Vidgoff, J. Selenium supplementation in low-birthweight premature infants: relationship to trace metals and antioxidant enzymes. JPEN J Parenter.Enteral Nutr 1991;15:556-559. View abstract.
  93. Schneider, M., Forster, H., Boersma, A., Seiler, A., Wehnes, H., Sinowatz, F., Neumuller, C., Deutsch, M. J., Walch, A., Hrabe de, Angelis M., Wurst, W., Ursini, F., Roveri, A., Maleszewski, M., Maiorino, M., and Conrad, M. Mitochondrial glutathione peroxidase 4 disruption causes male infertility. FASEB J 2009;23:3233-3242. View abstract.
  94. Hawkes, W. C., Alkan, Z., and Wong, K. Selenium supplementation does not affect testicular selenium status or semen quality in North American men. J Androl 2009;30:525-533. View abstract.
  95. Gartner, R. [Thyroid disorders during pregnancy]. Dtsch.Med Wochenschr. 2009;134:83-86. View abstract.
  96. Kamble, P., Mohsin, N., Jha, A., Date, A., Upadhaya, A., Mohammad, E., Khalil, M., Pakkyara, A., and Budruddin, M. Selenium intoxication with selenite broth resulting in acute renal failure and severe gastritis. Saudi.J Kidney Dis.Transpl. 2009;20:106-111. View abstract.
  97. Blazovics, A. [From free radicals to science of nutrition]. Orv.Hetil. 1-11-2009;150:53-63. View abstract.
  98. Saliba, W., El, Fakih R., and Shaheen, W. Heart failure secondary to selenium deficiency, reversible after supplementation. Int J Cardiol. 5-28-2010;141:e26-e27. View abstract.
  99. Hawkes, W. C. and Laslett, L. J. Selenium supplementation does not improve vascular responsiveness in healthy North American men. Am.J Physiol Heart Circ.Physiol 2009;296:H256-H262. View abstract.
  100. Schnabel, R., Lubos, E., Messow, C. M., Sinning, C. R., Zeller, T., Wild, P. S., Peetz, D., Handy, D. E., Munzel, T., Loscalzo, J., Lackner, K. J., and Blankenberg, S. Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study. Am.Heart J 2008;156:1201-1211. View abstract.
  101. Mocchegiani, E., Malavolta, M., Muti, E., Costarelli, L., Cipriano, C., Piacenza, F., Tesei, S., Giacconi, R., and Lattanzio, F. Zinc, metallothioneins and longevity: interrelationships with niacin and selenium. Curr.Pharm Des 2008;14:2719-2732. View abstract.
  102. Turner-McGrievy, G. M., Barnard, N. D., Cohen, J., Jenkins, D. J., Gloede, L., and Green, A. A. Changes in nutrient intake and dietary quality among participants with type 2 diabetes following a low-fat vegan diet or a conventional diabetes diet for 22 weeks. J Am.Diet.Assoc. 2008;108:1636-1645. View abstract.
  103. Jackson, M. I. and Combs, G. F., Jr. Selenium and anticarcinogenesis: underlying mechanisms. Curr.Opin.Clin.Nutr.Metab Care 2008;11:718-726. View abstract.
  104. Pappas, A. C., Zoidis, E., Surai, P. F., and Zervas, G. Selenoproteins and maternal nutrition. Comp Biochem.Physiol B Biochem.Mol.Biol. 2008;151:361-372. View abstract.
  105. Sanmartin, C., Plano, D., and Palop, J. A. Selenium compounds and apoptotic modulation: a new perspective in cancer therapy. Mini.Rev.Med Chem. 2008;8:1020-1031. View abstract.
  106. Benton, D. and Cook, R. The impact of selenium supplementation on mood. Biol.Psychiatry 6-1-1991;29:1092-1098. View abstract.
  107. Arasaradnam, R. P., Commane, D. M., Bradburn, D., and Mathers, J. C. A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics. 2008;3:193-198. View abstract.
  108. Navarro-Alarcon, M. and Cabrera-Vique, C. Selenium in food and the human body: a review. Sci Total Environ. 8-1-2008;400(1-3):115-141. View abstract.
  109. Margis, R., Dunand, C., Teixeira, F. K., and Margis-Pinheiro, M. Glutathione peroxidase family - an evolutionary overview. FEBS J 2008;275:3959-3970. View abstract.
  110. Daniels, L., Gibson, R. A., Simmer, K., Van, Dael P., and Makrides, M. Selenium status of term infants fed selenium-supplemented formula in a randomized dose-response trial. Am.J Clin.Nutr. 2008;88:70-76. View abstract.
  111. Orrell, R. W., Lane, R. J., and Ross, M. A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Amyotroph.Lateral.Scler. 2008;9:195-211. View abstract.
  112. Duntas, L. H. Environmental factors and autoimmune thyroiditis. Nat.Clin.Pract Endocrinol.Metab 2008;4:454-460. View abstract.
  113. Burney, P., Potts, J., Makowska, J., Kowalski, M., Phillips, J., Gnatiuc, L., Shaheen, S., Joos, G., Van, Cauwenberge P., van, Zele T., Verbruggen, K., van, Durme Y., Derudder, I., Wohrl, S., Godnic-Cvar, J., Salameh, B., Skadhauge, L., Thomsen, G., Zuberbier, T., Bergmann, K. C., Heinzerling, L., Renz, H., Al-Fakhri, N., Kosche, B., Hildenberg, A., Papadopoulos, N. G., Xepapadaki, P., Zannikos, K., Gjomarkaj, M., Bruno, A., Pace, E., Bonini, S., Bresciani, M., Gramiccioni, C., Fokkens, W., Weersink, E. J., Carlsen, K. H., Bakkeheim, E., Loureiro, C., Villanueva, C. M., Sanjuas, C., Zock, J. P., Lundback, B., and Janson, C. A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project. Allergy 2008;63:865-871. View abstract.
  114. Balazs, C. [The effect of selenium therapy on autoimmune thyroiditis]. Orv.Hetil. 6-29-2008;149:1227-1232. View abstract.
  115. Hawkes, W. C., Keim, N. L., Diane, Richter B., Gustafson, M. B., Gale, B., Mackey, B. E., and Bonnel, E. L. High-selenium yeast supplementation in free-living North American men: no effect on thyroid hormone metabolism or body composition. J Trace Elem.Med Biol. 2008;22:131-142. View abstract.
  116. Kupka, R., Mugusi, F., Aboud, S., Msamanga, G. I., Finkelstein, J. L., Spiegelman, D., and Fawzi, W. W. Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes. Am.J Clin.Nutr. 2008;87:1802-1808. View abstract.
  117. Trujillo, M., Ferrer-Sueta, G., and Radi, R. Peroxynitrite detoxification and its biologic implications. Antioxid.Redox.Signal. 2008;10:1607-1620. View abstract.
  118. Schweizer, U., Chiu, J., and Kohrle, J. Peroxides and peroxide-degrading enzymes in the thyroid. Antioxid.Redox.Signal. 2008;10:1577-1592. View abstract.
  119. Gomm, S. A., Thatcher, N., Cuthbert, A., Chang, J., Burmester, H., Hall, P., and Carroll, K. B. High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study. Br.J Cancer 1991;63:293-297. View abstract.
  120. Gosney, M. A., Hammond, M. F., Shenkin, A., and Allsup, S. Effect of micronutrient supplementation on mood in nursing home residents. Gerontology 2008;54:292-299. View abstract.
  121. Reid, M. E., Duffield-Lillico, A. J., Slate, E., Natarajan, N., Turnbull, B., Jacobs, E., Combs, G. F., Jr., Alberts, D. S., Clark, L. C., and Marshall, J. R. The nutritional prevention of cancer: 400 mcg per day selenium treatment. Nutr.Cancer 2008;60:155-163. View abstract.
  122. Mahata, J., Argos, M., Verret, W., Kibriya, M. G., Santella, R. M., and Ahsan, H. Effect of selenium and vitamin e supplementation on plasma protein carbonyl levels in patients with arsenic-related skin lesions. Nutr Cancer 2008;60:55-60. View abstract.
  123. Vincent, J. L. and Forceville, X. Critically elucidating the role of selenium. Curr Opin Anaesthesiol. 2008;21:148-154. View abstract.
  124. Thomson, A. Nutritional support in acute pancreatitis. Curr.Opin.Clin.Nutr.Metab Care 2008;11:261-266. View abstract.
  125. Meplan, C., Crosley, L. K., Nicol, F., Horgan, G. W., Mathers, J. C., Arthur, J. R., and Hesketh, J. E. Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. Am J Clin Nutr 2008;87:1019-1027. View abstract.
  126. Boosalis, M. G. The role of selenium in chronic disease. Nutr.Clin.Pract 2008;23:152-160. View abstract.
  127. Brigelius-Flohe, R. Selenium compounds and selenoproteins in cancer. Chem.Biodivers. 2008;5:389-395. View abstract.
  128. Katzen-Luchenta, J. The declaration of nutrition, health, and intelligence for the child-to-be. Nutr.Health 2007;19(1-2):85-102. View abstract.
  129. Salonen, J. T., Salonen, R., Seppanen, K., Rinta-Kiikka, S., Kuukka, M., Korpela, H., Alfthan, G., Kantola, M., and Schalch, W. Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status. Am.J Clin.Nutr. 1991;53:1222-1229. View abstract.
  130. Hawkes, W. C., Richter, B. D., Alkan, Z., Souza, E. C., Derricote, M., Mackey, B. E., and Bonnel, E. L. Response of selenium status indicators to supplementation of healthy North American men with high-selenium yeast. Biol Trace Elem.Res 2008;122:107-121. View abstract.
  131. Gammelgaard, B., Gabel-Jensen, C., Sturup, S., and Hansen, H. R. Complementary use of molecular and element-specific mass spectrometry for identification of selenium compounds related to human selenium metabolism. Anal.Bioanal.Chem 2008;390:1691-1706. View abstract.
  132. Vina, J., Sastre, J., Pallardo, F. V., Gambini, J., and Borras, C. Modulation of longevity-associated genes by estrogens or phytoestrogens. Biol Chem 2008;389:273-277. View abstract.
  133. Voitsekhovskaia, IuG, Skesters, A., Orlikov, G. A., Silova, A. A., Rusakova, N. E., Larmane, L. T., Karpov, IuG, Ivanov, A. D., and Maulins, E. [Assessment of some oxidative stress parameters in bronchial asthma patients beyond add-on selenium supplementation]. Biomed Khim. 2007;53:577-584. View abstract.
  134. Ravn-Haren, G., Krath, B. N., Overvad, K., Cold, S., Moesgaard, S., Larsen, E. H., and Dragsted, L. O. Effect of long-term selenium yeast intervention on activity and gene expression of antioxidant and xenobiotic metabolising enzymes in healthy elderly volunteers from the Danish Prevention of Cancer by Intervention by Selenium (PRECISE) pilot study. Br J Nutr 2008;99:1190-1198. View abstract.
  135. Beale, R. J., Sherry, T., Lei, K., Campbell-Stephen, L., McCook, J., Smith, J., Venetz, W., Alteheld, B., Stehle, P., and Schneider, H. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial. Crit Care Med. 2008;36:131-144. View abstract.
  136. Sanchez-Gutierrez, M., Garcia-Montalvo, E. A., Izquierdo-Vega, J. A., and Del Razo, L. M. Effect of dietary selenium deficiency on the in vitro fertilizing ability of mice spermatozoa. Cell Biol.Toxicol. 2008;24:321-329. View abstract.
  137. Flohe, L. Selenium in mammalian spermiogenesis. Biol.Chem. 2007;388:987-995. View abstract.
  138. Alexander, J. Selenium. Novartis.Found.Symp 2007;282:143-149. View abstract.
  139. Sidibe, el H. [Reflections on mental retardation and congenital hypothyroidism: effects of trace mineral deficiencies]. Sante 2007;17:41-50. View abstract.
  140. Bogatov, N. V. [Selenium deficiency and its dietary correction in patients with irritable bowel syndrome and chronic catarrhal colitis]. Vopr.Pitan. 2007;76:35-39. View abstract.
  141. Joniau, S., Goeman, L., Roskams, T., Lerut, E., Oyen, R., and Van Poppel, H. Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia. Urology 2007;69:1102-1106. View abstract.
  142. Houston, M. C. The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern Ther Health Med 2007;13:S128-S133. View abstract.
  143. Heyland, D. K., Dhaliwalm, R., Day, A., Drover, J., Cote, H., and Wischmeyer, P. Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study. JPEN J Parenter.Enteral Nutr 2007;31:109-118. View abstract.
  144. Negro, R., Greco, G., Mangieri, T., Pezzarossa, A., Dazzi, D., and Hassan, H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol.Metab 2007;92:1263-1268. View abstract.
  145. Yu, S. Y., Zhu, Y. J., Li, W. G., Huang, Q. S., Huang, C. Z., Zhang, Q. N., and Hou, C. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol.Trace Elem.Res. 1991;29:289-294. View abstract.
  146. Singh, U., Otvos, J., Dasgupta, A., de Lemos, J. A., Devaraj, S., and Jialal, I. High-dose alpha-tocopherol therapy does not affect HDL subfractions in patients with coronary artery disease on statin therapy. Clin Chem 2007;53:525-528. View abstract.
  147. Shaheen, S. O., Newson, R. B., Rayman, M. P., Wong, A. P., Tumilty, M. K., Phillips, J. M., Potts, J. F., Kelly, F. J., White, P. T., and Burney, P. G. Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma. Thorax 2007;62:483-490. View abstract.
  148. Dawczynski, J., Winnefeld, K., and Strobel, J. Selenium and zinc in patients with acute and chronic uveitis. Biol Trace Elem.Res 2006;113:131-137. View abstract.
  149. Mishra, V., Baines, M., Perry, S. E., McLaughlin, P. J., Carson, J., Wenstone, R., and Shenkin, A. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr 2007;26:41-50. View abstract.
  150. Narayanan, B. A. Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr.Cancer Drug Targets. 2006;6:711-727. View abstract.
  151. Angstwurm, M. W., Engelmann, L., Zimmermann, T., Lehmann, C., Spes, C. H., Abel, P., Strauss, R., Meier-Hellmann, A., Insel, R., Radke, J., Schuttler, J., and Gartner, R. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007;35:118-126. View abstract.
  152. Berger, M. M., Eggimann, P., Heyland, D. K., Chiolero, R. L., Revelly, J. P., Day, A., Raffoul, W., and Shenkin, A. Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomised trials. Crit Care 2006;10:R153. View abstract.
  153. Flores-Mateo, G., Navas-Acien, A., Pastor-Barriuso, R., and Guallar, E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr 2006;84:762-773. View abstract.
  154. Dawczynski, J., Winnefeld, K., Konigsdorffer, E., Augsten, R., Blum, M., and Strobel, J. [Selenium and cataract--risk factor or useful dietary supplement?]. Klin Monatsbl.Augenheilkd. 2006;223:675-680. View abstract.
  155. Richelle, M., Sabatier, M., Steiling, H., and Williamson, G. Skin bioavailability of dietary vitamin E, carotenoids, polyphenols, vitamin C, zinc and selenium. Br J Nutr 2006;96:227-238. View abstract.
  156. Czernichow, S., Couthouis, A., Bertrais, S., Vergnaud, A. C., Dauchet, L., Galan, P., and Hercberg, S. Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am J Clin Nutr 2006;84:395-399. View abstract.
  157. Groenbaek, K., Friis, H., Hansen, M., Ring-Larsen, H., and Krarup, H. B. The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients. Eur J Gastroenterol Hepatol 2006;18:985-989. View abstract.
  158. Spiller, H. A. and Pfiefer, E. Two fatal cases of selenium toxicity. Forensic Sci Int 8-24-2007;171:67-72. View abstract.
  159. McCarty, M. F. and Block, K. I. Preadministration of high-dose salicylates, suppressors of NF-kappaB activation, may increase the chemosensitivity of many cancers: an example of proapoptotic signal modulation therapy. Integr.Cancer Ther 2006;5:252-268. View abstract.
  160. Elango, N., Samuel, S., and Chinnakkannu, P. Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation. Clin Chim Acta 2006;373(1-2):92-98. View abstract.
  161. Serwin, A. B., Wasowicz, W., and Chodynicka, B. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B. Nutrition 2006;22:860-864. View abstract.
  162. Vanderpas, J. Nutritional epidemiology and thyroid hormone metabolism. Annu Rev Nutr 2006;26:293-322. View abstract.
  163. Cai, L., You, N. C., Lu, H., Mu, L. N., Lu, Q. Y., Yu, S. Z., Le, A. D., Marshall, J., Heber, D., and Zhang, Z. F. Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma. Cancer 6-1-2006;106:2345-2354. View abstract.
  164. Burk, R. F., Norsworthy, B. K., Hill, K. E., Motley, A. K., and Byrne, D. W. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol.Biomarkers Prev. 2006;15:804-810. View abstract.
  165. Stranges, S., Marshall, J. R., Trevisan, M., Natarajan, R., Donahue, R. P., Combs, G. F., Farinaro, E., Clark, L. C., and Reid, M. E. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol. 4-15-2006;163:694-699. View abstract.
  166. Kuklinski, B., Buchner, M., Schweder, R., and Nagel, R. [Acute pancreatitis--a free radical disease. Decrease in fatality with sodium selenite (Na2SeO3) therapy]. Z.Gesamte Inn.Med 1991;46:145-149. View abstract.
  167. van, Dokkum W., Van der Torre, H. W., Schaafsma, G., Kistemaker, C., and Ockhuizen, T. Supplementation with selenium-rich bread does not influence platelet aggregation in healthy volunteers. Eur.J Clin.Nutr. 1992;46:445-450. View abstract.
  168. Misso, N. L. and Thompson, P. J. Oxidative stress and antioxidant deficiencies in asthma: potential modification by diet. Redox Rep. 2005;10:247-255. View abstract.
  169. Frank, J. E. Diagnosis and management of G6PD deficiency. Am.Fam.Physician 10-1-2005;72:1277-1282. View abstract.
  170. Rayman, M., Thompson, A., Warren-Perry, M., Galassini, R., Catterick, J., Hall, E., Lawrence, D., and Bliss, J. Impact of selenium on mood and quality of life: a randomized, controlled trial. Biol Psychiatry 1-15-2006;59:147-154. View abstract.
  171. Mego, M., Koncekova, R., Mikuskova, E., Drgona, L., Ebringer, L., Demitrovicova, L., Nemova, I., Trupl, J., Mardiak, J., Koza, I., and Zajac, V. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study. Support.Care Cancer 2006;14:285-290. View abstract.
  172. Riccioni, G. and D'Orazio, N. The role of selenium, zinc and antioxidant vitamin supplementation in the treatment of bronchial asthma: adjuvant therapy or not? Expert.Opin Investig.Drugs 2005;14:1145-1155. View abstract.
  173. Fakih, M., Cao, S., Durrani, F. A., and Rustum, Y. M. Selenium protects against toxicity induced by anticancer drugs and augments antitumor activity: a highly selective, new, and novel approach for the treatment of solid tumors. Clin.Colorectal Cancer 2005;5:132-135. View abstract.
  174. Bodnar, L. M. and Wisner, K. L. Nutrition and depression: implications for improving mental health among childbearing-aged women. Biol Psychiatry 11-1-2005;58:679-685. View abstract.
  175. Volkovova, K., Barancokova, M., Kazimirova, A., Collins, A., Raslova, K., Smolkova, B., Horska, A., Wsolova, L., and Dusinska, M. Antioxidant supplementation reduces inter-individual variation in markers of oxidative damage. Free Radic.Res 2005;39:659-666. View abstract.
  176. Kim, J., Sun, P., Lam, Y. W., Troncoso, P., Sabichi, A. L., Babaian, R. J., Pisters, L. L., Pettaway, C. A., Wood, C. G., Lippman, S. M., McDonnell, T. J., Lieberman, R., Logothetis, C., and Ho, S. M. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer. Cancer Epidemiol.Biomarkers Prev. 2005;14:1697-1702. View abstract.
  177. Burk, R. F. and Hill, K. E. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 2005;25:215-235. View abstract.
  178. Meltzer, H. M., Norheim, G., Loken, E. B., and Holm, H. Supplementation with wheat selenium induces a dose-dependent response in serum and urine of a Se-replete population. Br.J Nutr. 1992;67:287-294. View abstract.
  179. Jackson, M. J., Dillon, S. A., Broome, C. S., McArdle, A., Hart, C. A., and McArdle, F. Are there functional consequences of a reduction in selenium intake in UK subjects? Proc.Nutr.Soc. 2004;63:513-517. View abstract.
  180. Xia, Y., Hill, K. E., Byrne, D. W., Xu, J., and Burk, R. F. Effectiveness of selenium supplements in a low-selenium area of China. Am.J.Clin.Nutr. 2005;81:829-834. View abstract.
  181. Mego, M., Ebringer, L., Drgona, L., Mardiak, J., Trupl, J., Greksak, R., Nemova, I., Oravcova, E., Zajac, V., and Koza, I. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. Neoplasma 2005;52:159-164. View abstract.
  182. Chelchowska, M., Laskowska-Klita, T., Kubik, P., and Leibschang, J. [The effect of vitamin-mineral supplementation on the level of MDA and activity of glutathione peroxidase and superoxide dismutase in blood of matched maternal-cord pairs]. Przegl.Lek. 2004;61:760-763. View abstract.
  183. Bonnefont-Rousselot, D. The role of antioxidant micronutrients in the prevention of diabetic complications. Treat.Endocrinol 2004;3:41-52. View abstract.
  184. Dodig, S. and Cepelak, I. The facts and controversies about selenium. Acta Pharm 2004;54:261-276. View abstract.
  185. Lindner, D., Lindner, J., Baumann, G., Dawczynski, H., and Bauch, K. [Investigation of antioxidant therapy with sodium selenite in acute pancreatitis. A prospective randomized blind trial]. Med Klin.(Munich) 12-15-2004;99:708-712. View abstract.
  186. McClelland, R. S., Baeten, J. M., Overbaugh, J., Richardson, B. A., Mandaliya, K., Emery, S., Lavreys, L., Ndinya-Achola, J. O., Bankson, D. D., Bwayo, J. J., and Kreiss, J. K. Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial. J Acquir.Immune.Defic.Syndr. 12-15-2004;37:1657-1663. View abstract.
  187. Peretz, A., Neve, J., Duchateau, J., and Famaey, J. P. Adjuvant treatment of recent onset rheumatoid arthritis by selenium supplementation: preliminary observations. Br.J Rheumatol. 1992;31:281-282. View abstract.
  188. Smolkova, B., Dusinska, M., Raslova, K., Barancokova, M., Kazimirova, A., Horska, A., Spustova, V., and Collins, A. Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk. Mutagenesis 2004;19:469-476. View abstract.
  189. Rayman, M. P. The use of high-selenium yeast to raise selenium status: how does it measure up? Br.J Nutr. 2004;92:557-573. View abstract.
  190. Subudhi, A. W., Jacobs, K. A., Hagobian, T. A., Fattor, J. A., Fulco, C. S., Muza, S. R., Rock, P. B., Hoffman, A. R., Cymerman, A., and Friedlander, A. L. Antioxidant supplementation does not attenuate oxidative stress at high altitude. Aviat.Space Environ.Med 2004;75:881-888. View abstract.
  191. Reid, M. E., Stratton, M. S., Lillico, A. J., Fakih, M., Natarajan, R., Clark, L. C., and Marshall, J. R. A report of high-dose selenium supplementation: response and toxicities. J Trace Elem.Med Biol. 2004;18:69-74. View abstract.
  192. Pan, S. Y., Ugnat, A. M., Mao, Y., Wen, S. W., and Johnson, K. C. A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol.Biomarkers Prev. 2004;13:1521-1527. View abstract.
  193. Faure, P., Ramon, O., Favier, A., and Halimi, S. Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. Eur.J Clin.Invest 2004;34:475-481. View abstract.
  194. Weijl, N. I., Elsendoorn, T. J., Lentjes, E. G., Hopman, G. D., Wipkink-Bakker, A., Zwinderman, A. H., Cleton, F. J., and Osanto, S. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur.J Cancer 2004;40:1713-1723. View abstract.
  195. Angstwurm, M. W., Schopohl, J., and Gaertner, R. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. Eur.J Endocrinol. 2004;151:47-54. View abstract.
  196. Broome, C. S., McArdle, F., Kyle, J. A., Andrews, F., Lowe, N. M., Hart, C. A., Arthur, J. R., and Jackson, M. J. An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am.J.Clin.Nutr. 2004;80:154-162. View abstract.
  197. Allam, M. F. and Lucane, R. A. Selenium supplementation for asthma. Cochrane.Database.Syst.Rev. 2004;:CD003538. View abstract.
  198. Sakaguchi, S. [Metabolic aspects of endotoxin as a model of septic shock--approached from oxidative stress]. Yakugaku Zasshi 2004;124:69-87. View abstract.
  199. Al-Taie, O. H., Seufert, J., Karvar, S., Adolph, C., Mork, H., Scheurlen, M., Kohrle, J., and Jakob, F. Selenium supplementation enhances low selenium levels and stimulates glutathione peroxidase activity in peripheral blood and distal colon mucosa in past and present carriers of colon adenomas. Nutr.Cancer 2003;46:125-130. View abstract.
  200. Allsup, S. J., Shenkin, A., Gosney, M. A., Taylor, S., Taylor, W., Hammond, M., and Zambon, M. C. Can a short period of micronutrient supplementation in older institutionalized people improve response to influenza vaccine? A randomized, controlled trial. J Am.Geriatr.Soc. 2004;52:20-24. View abstract.
  201. Schrauzer, G. N. The nutritional significance, metabolism and toxicology of selenomethionine. Adv.Food Nutr.Res. 2003;47:73-112. View abstract.
  202. Pietschmann, A., Kuklinski, B., and Otterstein, A. [Protection from uv-light-induced oxidative stress by nutritional radical scavengers]. Z.Gesamte Inn.Med 1992;47:518-522. View abstract.
  203. Darlow, B. A. and Austin, N. C. Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane.Database.Syst.Rev. 2003;:CD003312. View abstract.
  204. Serwin, A. B., Mysliwiec, H., Hukalowicz, K., Porebski, P., Borawska, M., and Chodynicka, B. Soluble tumor necrosis factor-alpha receptor type 1 during selenium supplementation in psoriasis patients. Nutrition 2003;19:847-850. View abstract.
  205. Contempre, B., Duale, N. L., Dumont, J. E., Ngo, B., Diplock, A. T., and Vanderpas, J. Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clin Endocrinol.(Oxf) 1992;36:579-583. View abstract.
  206. Li, W. G. [Preliminary observations on effect of selenium yeast on high risk populations with primary liver cancer]. Zhonghua Yu Fang Yi.Xue.Za Zhi. 1992;26:268-271. View abstract.
  207. Abrams, C. K., Siram, S. M., Galsim, C., Johnson-Hamilton, H., Munford, F. L., and Mezghebe, H. Selenium deficiency in long-term total parenteral nutrition. Nutr Clin Pract 1992;7:175-178. View abstract.
  208. Singhal, N. and Austin, J. A clinical review of micronutrients in HIV infection. J Int Assoc.Physicians AIDS Care (Chic.) 2002;1:63-75. View abstract.
  209. Shor-Posner, G., Lecusay, R., Miguez, M. J., Moreno-Black, G., Zhang, G., Rodriguez, N., Burbano, X., Baum, M., and Wilkie, F. Psychological burden in the era of HAART: impact of selenium therapy. Int J Psychiatry Med 2003;33:55-69. View abstract.
  210. Hou, J., Wu, Y., and Ling, Y. [Modulation of the inflammatory response through complement-neutrophil activation feedback mechanism with selenium and vitamin E]. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 2000;22:580-584. View abstract.
  211. Ferencik, M. and Ebringer, L. Modulatory effects of selenium and zinc on the immune system. Folia Microbiol.(Praha) 2003;48:417-426. View abstract.
  212. Wallace, K., Byers, T., Morris, J. S., Cole, B. F., Greenberg, E. R., Baron, J. A., Gudino, A., Spate, V., and Karagas, M. R. Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study. Cancer Epidemiol.Biomarkers Prev. 2003;12:464-467. View abstract.
  213. Bertolini, G., Iapichino, G., Radrizzani, D., Facchini, R., Simini, B., Bruzzone, P., Zanforlin, G., and Tognoni, G. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med. 2003;29:834-840. View abstract.
  214. Margaritis, I., Palazzetti, S., Rousseau, A. S., Richard, M. J., and Favier, A. Antioxidant supplementation and tapering exercise improve exercise-induced antioxidant response. J Am.Coll.Nutr. 2003;22:147-156. View abstract.
  215. Keskes-Ammar, L., Feki-Chakroun, N., Rebai, T., Sahnoun, Z., Ghozzi, H., Hammami, S., Zghal, K., Fki, H., Damak, J., and Bahloul, A. Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch.Androl 2003;49:83-94. View abstract.
  216. Venn, B. J., Grant, A. M., Thomson, C. D., and Green, T. J. Selenium supplements do not increase plasma total homocysteine concentrations in men and women. J Nutr. 2003;133:418-420. View abstract.
  217. Kelley, M. J. and McCrory, D. C. Prevention of lung cancer: summary of published evidence. Chest 2003;123(1 Suppl):50S-59S. View abstract.
  218. Benton, D. Selenium intake, mood and other aspects of psychological functioning. Nutr.Neurosci. 2002;5:363-374. View abstract.
  219. Burbano, X., Miguez-Burbano, M. J., McCollister, K., Zhang, G., Rodriguez, A., Ruiz, P., Lecusay, R., and Shor-Posner, G. Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants. HIV.Clin.Trials 2002;3:483-491. View abstract.
  220. Bialy, T. L., Rothe, M. J., and Grant-Kels, J. M. Dietary factors in the prevention and treatment of nonmelanoma skin cancer and melanoma. Dermatol.Surg. 2002;28:1143-1152. View abstract.
  221. El-Bayoumy, K., Richie, J. P., Jr., Boyiri, T., Komninou, D., Prokopczyk, B., Trushin, N., Kleinman, W., Cox, J., Pittman, B., and Colosimo, S. Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study. Cancer Epidemiol.Biomarkers Prev. 2002;11:1459-1465. View abstract.
  222. Apostolidis, N. S., Panoussopoulos, D. G., Stamou, K. M., Kekis, P. B., Paradellis, T. P., Karydas, A. G., Zarkadas, C., Zirogiannis, P. N., and Manouras, A. J. Selenium metabolism in patients on continuous ambulatory peritoneal dialysis. Perit.Dial.Int 2002;22:400-404. View abstract.
  223. Whanger, P. D. Selenocompounds in plants and animals and their biological significance. J Am.Coll.Nutr. 2002;21:223-232. View abstract.
  224. Gazdik, F., Kadrabova, J., and Gazdikova, K. Decreased consumption of corticosteroids after selenium supplementation in corticoid-dependent asthmatics. Bratisl.Lek.Listy 2002;103:22-25. View abstract.
  225. Gazdik, F., Horvathova, M., Gazdikova, K., and Jahnova, E. The influence of selenium supplementation on the immunity of corticoid-dependent asthmatics. Bratisl.Lek.Listy 2002;103:17-21. View abstract.
  226. Jahnova, E., Horvathova, M., Gazdik, F., and Weissova, S. Effects of selenium supplementation on expression of adhesion molecules in corticoid-dependent asthmatics. Bratisl.Lek.Listy 2002;103:12-16. View abstract.
  227. Vinceti, M., Wei, E. T., Malagoli, C., Bergomi, M., and Vivoli, G. Adverse health effects of selenium in humans. Rev.Environ.Health 2001;16:233-251. View abstract.
  228. Sole, M. J. and Jeejeebhoy, K. N. Conditioned nutritional requirements: therapeutic relevance to heart failure. Herz 2002;27:174-178. View abstract.
  229. Adamowicz, A., Trafikowska, U., Trafikowska, A., Zachara, B., and Manitius, J. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long- term hemodialysis. Med Sci Monit. 2002;8:CR202-CR205. View abstract.
  230. Burke, M. P. and Opeskin, K. Fulminant heart failure due to selenium deficiency cardiomyopathy (Keshan disease). Med Sci Law 2002;42:10-13. View abstract.
  231. Yusuf, S. W., Rehman, Q., and Casscells, W. Cardiomyopathy in association with selenium deficiency: a case report. JPEN J Parenter.Enteral Nutr. 2002;26:63-66. View abstract.
  232. Cornelli, U., Terranova, R., Luca, S., Cornelli, M., and Alberti, A. Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr. 2001;131:3208-3211. View abstract.
  233. Ogawa, A., Ogawa, I., Obayashi, R., Umezu, K., Doi, M., and Hirao, T. Highly Selective Thioselenation of Vinylcyclopropanes with a (PhS)-(PhSe) Binary System and Its Application to Thiotelluration. J Org.Chem. 1-8-1999;64:86-92. View abstract.
  234. Elsendoorn, T. J., Weijl, N. I., Mithoe, S., Zwinderman, A. H., Van, Dam F., De Zwart, F. A., Tates, A. D., and Osanto, S. Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo. Mutat.Res. 11-15-2001;498(1-2):145-158. View abstract.
  235. Kiremidjian-Schumacher, L. and Roy, M. Effect of selenium on the immunocompetence of patients with head and neck cancer and on adoptive immunotherapy of early and established lesions. Biofactors 2001;14(1-4):161-168. View abstract.
  236. Kalita, B., Nowak, P., Slimok, M., Sikora, A., Szkilnik, R., Obuchowicz, A., Sulej, J., and Sabat, D. [Selenium plasma concentration level in children with food allergy]. Pol.Merkur Lekarski. 2001;10:411-413. View abstract.
  237. Federico, A., Iodice, P., Federico, P., Del Rio, A., Mellone, M. C., Catalano, G., and Federico, P. Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. Eur J Clin Nutr 2001;55:293-297. View abstract.
  238. Miller, A. L. The etiologies, pathophysiology, and alternative/complementary treatment of asthma. Altern.Med Rev. 2001;6:20-47. View abstract.
  239. Alfthan, G., Xu, G. L., Tan, W. H., Aro, A., Wu, J., Yang, Y. X., Liang, W. S., Xue, W. L., and Kong, L. H. Selenium supplementation of children in a selenium-deficient area in China: blood selenium levels and glutathione peroxidase activities. Biol.Trace Elem.Res. 2000;73:113-125. View abstract.
  240. Seppanen, K., Kantola, M., Laatikainen, R., Nyyssonen, K., Valkonen, V. P., Kaarlopp, V., and Salonen, J. T. Effect of supplementation with organic selenium on mercury status as measured by mercury in pubic hair. J Trace Elem.Med Biol. 2000;14:84-87. View abstract.
  241. Winterbourn, C. C., Chan, T., Buss, I. H., Inder, T. E., Mogridge, N., and Darlow, B. A. Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: associations with chronic lung disease and retinopathy and effects of selenium supplementation. Pediatr.Res. 2000;48:84-90. View abstract.
  242. Brown, K. M., Pickard, K., Nicol, F., Beckett, G. J., Duthie, G. G., and Arthur, J. R. Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes, platelets and erythrocytes. Clin.Sci (Lond) 2000;98:593-599. View abstract.
  243. Darlow, B. A., Winterbourn, C. C., Inder, T. E., Graham, P. J., Harding, J. E., Weston, P. J., Austin, N. C., Elder, D. E., Mogridge, N., Buss, I. H., and Sluis, K. B. The effect of selenium supplementation on outcome in very low birth weight infants: a randomized controlled trial. The New Zealand Neonatal Study Group. J Pediatr 2000;136:473-480. View abstract.
  244. Finley, J. W., Duffield, A., Ha, P., Vanderpool, R. A., and Thomson, C. D. Selenium supplementation affects the retention of stable isotopes of selenium in human subjects consuming diets low in selenium. Br.J Nutr. 1999;82:357-360. View abstract.
  245. Temple, K. A., Smith, A. M., and Cockram, D. B. Selenate-supplemented nutritional formula increases plasma selenium in hemodialysis patients. J Ren Nutr. 2000;10:16-23. View abstract.
  246. Welch, R. W., Turley, E., Sweetman, S. F., Kennedy, G., Collins, A. R., Dunne, A., Livingstone, M. B., McKenna, P. G., McKelvey-Martin, V. J., and Strain, J. J. Dietary antioxidant supplementation and DNA damage in smokers and nonsmokers. Nutr.Cancer 1999;34:167-172. View abstract.
  247. Schumacher, K. [Effect of selenium on the side effect profile of adjuvant chemotherapy/radiotherapy in patients with breast carcinoma. Design for a clinical study]. Med Klin.(Munich) 10-15-1999;94 Suppl 3:45-48. View abstract.
  248. Chao, W. H., Askew, E. W., Roberts, D. E., Wood, S. M., and Perkins, J. B. Oxidative stress in humans during work at moderate altitude. J Nutr. 1999;129:2009-2012. View abstract.
  249. Pfeiffer, J. M., Askew, E. W., Roberts, D. E., Wood, S. M., Benson, J. E., Johnson, S. C., and Freedman, M. S. Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training. Wilderness.Environ.Med 1999;10:66-74. View abstract.
  250. Barceloux, D. G. Selenium. J Toxicol.Clin.Toxicol. 1999;37:145-172. View abstract.
  251. Ciliberto, H., Ciliberto, M., Briend, A., Ashorn, P., Bier, D., and Manary, M. Antioxidant supplementation for the prevention of kwashiorkor in Malawian children: randomised, double blind, placebo controlled trial. BMJ 5-14-2005;330:1109. View abstract.
  252. Olsen, A., Thiong'o, F. W., Ouma, J. H., Mwaniki, D., Magnussen, P., Michaelsen, K. F., Friis, H., and Geissler, P. W. Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren. Trans.R.Soc.Trop.Med.Hyg. 2003;97:109-114. View abstract.
  253. Singletary, K. and Milner, J. Diet, autophagy, and cancer: a review. Cancer Epidemiol.Biomarkers Prev. 2008;17:1596-1610. View abstract.
  254. Rana, S. V. Metals and apoptosis: recent developments. J.Trace Elem.Med.Biol. 2008;22:262-284. View abstract.
  255. Safarinejad, M. R. and Safarinejad, S. Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J Urol. 2009;181:741-751. View abstract.
  256. Rumiris, D., Purwosunu, Y., Wibowo, N., Farina, A., and Sekizawa, A. Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status. Hypertens.Pregnancy. 2006;25:241-253. View abstract.
  257. Davison, G. W., Hughes, C. M., and Bell, R. A. Exercise and mononuclear cell DNA damage: the effects of antioxidant supplementation. Int J Sport Nutr Exerc.Metab 2005;15:480-492. View abstract.
  258. Heinrich, U., Tronnier, H., Stahl, W., Bejot, M., and Maurette, J. M. Antioxidant supplements improve parameters related to skin structure in humans. Skin Pharmacol Physiol 2006;19:224-231. View abstract.
  259. Block, K. I., Koch, A. C., Mead, M. N., Tothy, P. K., Newman, R. A., and Gyllenhaal, C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int.J Cancer 9-15-2008;123:1227-1239. View abstract.
  260. Moreno-Reyes, R., Mathieu, F., Boelaert, M., Begaux, F., Suetens, C., Rivera, M. T., Neve, J., Perlmutter, N., and Vanderpas, J. Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. Am J Clin Nutr 2003;78:137-144. View abstract.
  261. Dunstan, J. A., Breckler, L., Hale, J., Lehmann, H., Franklin, P., Lyons, G., Ching, S. Y., Mori, T. A., Barden, A., and Prescott, S. L. Supplementation with vitamins C, E, beta-carotene and selenium has no effect on anti-oxidant status and immune responses in allergic adults: a randomized controlled trial. Clin Exp.Allergy 2007;37:180-187. View abstract.
  262. Zhang, L., Gail, M. H., Wang, Y. Q., Brown, L. M., Pan, K. F., Ma, J. L., Amagase, H., You, W. C., and Moslehi, R. A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. Am.J.Clin.Nutr. 2006;84:912-919. View abstract.
  263. Li, H., Li, H. Q., Wang, Y., Xu, H. X., Fan, W. T., Wang, M. L., Sun, P. H., and Xie, X. Y. An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum. Chin Med.J.(Engl.) 2004;117:1155-1160. View abstract.
  264. Kubik, P., Kowalska, B., Laskowska-Klita, T., Chelchowska, M., and Leibschang, J. [Effect of vitamin-mineral supplementation on the status of some microelements in pregnant women]. Przegl.Lek. 2004;61:764-768. View abstract.
  265. Lockwood, K., Moesgaard, S., Hanioka, T., and Folkers, K. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol.Aspects Med 1994;15 Suppl:s231-s240. View abstract.
  266. Pepe, S., Leong, J. Y., Van der Merwe, J., Marasco, S. F., Hadj, A., Lymbury, R., Perkins, A., and Rosenfeldt, F. L. Targeting oxidative stress in surgery: effects of ageing and therapy. Exp.Gerontol. 2008;43:653-657. View abstract.
  267. Witte, K. K., Nikitin, N. P., Parker, A. C., von Haehling, S., Volk, H. D., Anker, S. D., Clark, A. L., and Cleland, J. G. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005;26:2238-2244. View abstract.
  268. Hoenjet, K. M., Dagnelie, P. C., Delaere, K. P., Wijckmans, N. E., Zambon, J. V., and Oosterhof, G. O. Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study. Eur Urol 2005;47:433-439. View abstract.
  269. Hofstad, B., Almendingen, K., Vatn, M., Andersen, S. N., Owen, R. W., Larsen, S., and Osnes, M. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 1998;59:148-156. View abstract.
  270. Wenzel, G., Kuklinski, B., Ruhlmann, C., and Ehrhardt, D. [Alcohol-induced toxic hepatitis--a "free radical" associated disease. Lowering fatality by adjuvant antioxidant therapy]. Z.Gesamte Inn.Med. 1993;48:490-496. View abstract.
  271. Bjelakovic, G., Nikolova, D., Simonetti, R. G., and Gluud, C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane.Database.Syst.Rev. 2008;:CD004183. View abstract.
  272. Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., and Gluud, C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane.Database.Syst.Rev. 2008;:CD007176. View abstract.
  273. Evans, J. R. and Henshaw, K. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane.Database.Syst.Rev. 2008;:CD000253. View abstract.
  274. Bardia, A., Tleyjeh, I. M., Cerhan, J. R., Sood, A. K., Limburg, P. J., Erwin, P. J., and Montori, V. M. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. Mayo Clin.Proc. 2008;83:23-34. View abstract.
  275. Hercberg, S., Ezzedine, K., Guinot, C., Preziosi, P., Galan, P., Bertrais, S., Estaquio, C., Briancon, S., Favier, A., Latreille, J., and Malvy, D. Antioxidant supplementation increases the risk of skin cancers in women but not in men. J.Nutr. 2007;137:2098-2105. View abstract.
  276. Bleys, J., Miller, E. R., III, Pastor-Barriuso, R., Appel, L. J., and Guallar, E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am.J Clin.Nutr 2006;84:880-887. View abstract.
  277. Kamangar, F., Qiao, Y. L., Yu, B., Sun, X. D., Abnet, C. C., Fan, J. H., Mark, S. D., Zhao, P., Dawsey, S. M., and Taylor, P. R. Lung cancer chemoprevention: a randomized, double-blind trial in Linxian, China. Cancer Epidemiol.Biomarkers Prev. 2006;15:1562-1564. View abstract.
  278. Huang, H. Y., Caballero, B., Chang, S., Alberg, A. J., Semba, R. D., Schneyer, C. R., Wilson, R. F., Cheng, T. Y., Vassy, J., Prokopowicz, G., Barnes, G. J., and Bass, E. B. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann.Intern.Med. 9-5-2006;145:372-385. View abstract.
  279. Bjelakovic, G., Nagorni, A., Nikolova, D., Simonetti, R. G., Bjelakovic, M., and Gluud, C. Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment.Pharmacol Ther 7-15-2006;24:281-291. View abstract.
  280. Coulter, I. D., Hardy, M. L., Morton, S. C., Hilton, L. G., Tu, W., Valentine, D., and Shekelle, P. G. Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer. J Gen.Intern Med 2006;21:735-744. View abstract.
  281. McNaughton, S. A., Marks, G. C., and Green, A. C. Role of dietary factors in the development of basal cell cancer and squamous cell cancer of the skin. Cancer Epidemiol.Biomarkers Prev. 2005;14:1596-1607. View abstract.
  282. Bjelakovic, G., Nikolova, D., Simonetti, R. G., and Gluud, C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane.Database.Syst.Rev. 2004;:CD004183. View abstract.
  283. Wood, L. G., Fitzgerald, D. A., Lee, A. K., and Garg, M. L. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am.J.Clin.Nutr. 2003;77:150-159. View abstract.
  284. Prince, M. I., Mitchison, H. C., Ashley, D., Burke, D. A., Edwards, N., Bramble, M. G., James, O. F., and Jones, D. E. Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment.Pharmacol.Ther. 2003;17:137-143. View abstract.
  285. Greul, A. K., Grundmann, J. U., Heinrich, F., Pfitzner, I., Bernhardt, J., Ambach, A., Biesalski, H. K., and Gollnick, H. Photoprotection of UV-irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium and proanthocyanidins. Skin Pharmacol Appl.Skin Physiol 2002;15:307-315. View abstract.
  286. Schmidt, M. C., Askew, E. W., Roberts, D. E., Prior, R. L., Ensign, W. Y., Jr., and Hesslink, R. E., Jr. Oxidative stress in humans training in a cold, moderate altitude environment and their response to a phytochemical antioxidant supplement. Wilderness.Environ.Med. 2002;13:94-105. View abstract.
  287. Rooney, J. P. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology 5-20-2007;234:145-156. View abstract.
  288. Kies, C. and Harms, J. M. Copper absorption as affected by supplemental calcium, magnesium, manganese, selenium and potassium. Adv.Exp.Med Biol. 1989;258:45-58. View abstract.
  289. Mutanen, M. and Mykkanen, H. M. Effect of ascorbic acid supplementation on selenium bioavailability in humans. Hum.Nutr.Clin.Nutr. 1985;39:221-226. View abstract.
  290. Rivera JA, González-Cossío T, Flores M, et al. Multiple micronutrient supplementation increases the growth of Mexican infants. Am J Clin Nutr. 2001 Nov;74:657-63. View abstract.
  291. Rayman MP, Stranges S, Griffin BA, et al. Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial. Ann Intern Med 2011;154:656-65. View abstract.
  292. Balaz C, Feher J. The effect of selenium therapy on autoimmune thyroiditis. Clinical and Experimental Medical Journal 2009;3:269-77.
  293. Toulis KA, Anastasilakis AD, Tzellos TG, et al. Selenium supplementation in the treatment of Hashimoto's thyroiditis: A systematic review and a meta-analysis. Thyroid 2010;20:1163-73. View abstract.
  294. Bonfig W, Gartner R, Schmidt H. Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. ScientificWorldJournal 2010;10:990-6. View abstract.
  295. Mazokopakis EE, Papadakis JA, Papadomanolaki MG, et al. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto's thyroiditis. Thyroid 2007;17:609-12. View abstract.
  296. Turker O, Kumanlioglu K, Karapolat I, Dogan I. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J Endocrinol 2006;190:151-6. View abstract.
  297. Gartner R, Gasinier BC. Selenium in the treatment of autoimmune thyroiditis. Biofactors 2003;19:165-70. View abstract.
  298. Duntas LH, Mantzou E, Koutras DA. Effects of a six month treatment with selenomethionine in patients with autoimmune throiditis. Eur J Endocrinol 2003;148:389-93. View abstract.
  299. Rayman MP, Thompson AJ, Bekaert B, et al. Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. Am J Clin Nutr 2008;87:370-8. View abstract.
  300. Olivieri O, Girelli D, Azzini M, et al. Low selenium status in the elderly influences thyroid hormones. Clin Sci (Lond) 1995;89:637-42. View abstract.
  301. Reid SM, Middleton P, Cossich MC, Crowther CA. Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database Syst Rev 2010;:CD007752. View abstract.
  302. Stranges S, Laclaustra M, Ji C, et al. Higher selenium status is associated with adverse blood lipid profile in British adults. J Nutr 2010;140:81-7. View abstract.
  303. Aldosary BM, Sutter ME, Schwartz M, Morgan BW. Case series of selenium toxicity from a nutritional supplement. Clin Toxicol 2012;50:57-64. View abstract.
  304. Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality amoung US adults. Arch Intern Med 2008;168:404-10. View abstract.
  305. Lippmann SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 2009;301:39-51. View abstract.
  306. Sutter ME, Thomas JD, Brown J, Morgan B. Selenium toxicity: a case of selenosis caused by a nutritional supplement. Ann Intern Med 2008;148:970-1. View abstract.
  307. Stranges S, Marshall JR, Natarajan R, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes. Ann Intern Med 2007;147:217-23. View abstract.
  308. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in U.S. adults. Diabetes Care 2007;30:829-34. View abstract.
  309. Rajpathak S, Rimm E, Morris JS, Hu F. Toenail selenium and cardiovascular disease in men with diabetes. J Am Coll Nutr 2005;24:250-6. View abstract.
  310. Avenell A, Noble DW, Barr J, Engelhardt T. Selenium supplementation for critically ill adults. Cochrane Database Syst Rev 2004;:CD003703. View abstract.
  311. Dennert G, Horneber M. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. Cochrane Database Syst Rev 2006;:CD005037. View abstract.
  312. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007;297:842-57. View abstract.
  313. Hurwitz BE, Klaus JR, Llabre MM, et al. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med 2007;167:148-54. View abstract.
  314. See KA, Lavercombe PS, Dillon J, Ginsberg R. Accidental death from acute selenium poisoning. Med J Aust 2006;185:388-9. View abstract.
  315. Ishikawa M, Sasaki M, Koiwai K, et al. Inhibition of hepatic mixed-function oxidase enzymes in mice by acute and chronic treatment with selenium. J Pharmacobiodyn 1992;15:377-85. View abstract.
  316. Debski B, Milner JA. Dietary selenium supplementation prolongs pentobarbital induced hypnosis. J Nutr Biochem 2004;15:548-53. View abstract.
  317. Vermeulen NP, Baldew GS, Los G, et al. Reduction of cisplatin nephrotoxicity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compounds. Drug Metab Dispos 1993;21:30-6. View abstract.
  318. Baldew GS, Mol JG, de Kanter FJ, et al. The mechanism of interaction between cisplatin and selenite. Biochem Pharmacol 1991;41:1429-37. View abstract.
  319. Baldew GS, van den Hamer CJ, Los G, et al. Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats. Cancer Res 1989;49:3020-3. View abstract.
  320. Vernie LN, de Goeij JJ, Zegers C, et al. Cisplatin-induced changes of selenium levels and glutathione peroxidase activities in blood of testis tumor patients. Cancer Lett 1988;40:83-91. View abstract.
  321. Duffield AJ, Thomson CD, Hill KE, Williams S. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr 1999;70:896-903. View abstract.
  322. Calomme MR, Vanderpas JB, Francois B, et al. Thyroid function parameters during a selenium repletion/depletion study in phenylketonuric subjects. Experientia 1995;51:1208-15. View abstract.
  323. Hofbauer LC, Spitzweg C, Magerstadt RA, Heufelder AE. Selenium-induced thyroid dysfunction. Postgrad Med J 1997;73:103-4. View abstract.
  324. Vanderpas JB, Contempre B, Duale NL, et al. Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects. Am J Clin Nutr 1993;57:271S-5S. View abstract.
  325. Contempre B, Dumont JE, Ngo B, et al. Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J Clin Endocrinol Metab 1991;73:213-5. View abstract.
  326. Dillard CJ, Tappel AL. Are some major in vivo effects of gold related to microenvironments of decreased selenium? Med Hypotheses 1986;20:407-20. View abstract.
  327. Gregus Z, Gyurasics A, Csanaky I. Effects of arsenic-, platinum-, and gold-containing drugs on the disposition of exogenous selenium in rats. Toxicolog Sci 2000;57:22-31. View abstract.
  328. Capel ID, Jenner M, Williams DC, et al. The effect of prolonged oral contraceptive steroid use on erythrocyte glutathione peroxidase activity. J Steroid Biochem 1981;14:729-32. View abstract.
  329. Lloyd B, Lloyd RS, Clayton BE. Effect of smoking, alcohol and other factors on the selenium status of a healthy population. J Epidemiol Commun Health 1983;37:213-7. View abstract.
  330. Heese HD, Lawrence MA, Dempster WS, Pocock F. Reference concentrations of serum selenium and manganese in healthy nulliparas. S Afr Med J 1988;73:163-5. View abstract.
  331. Vaddadi KS, Soosai E, Vaddadi G. Low blood selenium concentrations in schizophrenic patients on clozapine. Br J Clin Pharmacol 2003;55:307-9. View abstract.
  332. Linday LA, Pippenger CE, Howard A, Lieberman JA. Free radical scavenging enzyme activity and related trace metals in clozapine-induced agranulocytosis: a pilot study. J Clin Psychopharmacol 1995;15:353-60. View abstract.
  333. Davila JC, Edds GT, Osuna O, Simpson CF. Modification of the effects of aflatoxin B1 and warfarin in young pigs given selenium. Am J Vet Res 1983;44:1877-83. View abstract.
  334. Schiavon R, Freeman GE, Guidi GC, et al. Selenium enhances prostacyclin production by cultured endothelial cells: possible explanation for increased bleeding times in volunteers taking selenium as a dietary supplement. Thromb Res 1984;34:389-96. View abstract.
  335. Watanabe C, Kim CY, Satoh H. Tissue-specific modification of selenium concentration by acute and chronic dexamethasone administration in mice. Br J Nutr 1997;78:501-9. View abstract.
  336. Fenech AG, Ellul-Micallef R. Selenium, glutathione peroxidase and superoxide dismutase in Maltese asthmatic patients: effect of glucocorticoid administration. Pulm Pharmacol Ther 1998;11:301-8. View abstract.
  337. Koskelo EK. Serum selenium in children during anti-cancer chemotherapy. Eur J Clin Nutr 1990;44:799-802. View abstract.
  338. Marano G, Fischioni P, Graziano C, et al. Increased serum selenium levels in patients under corticosteroid treatment. Pharmacol Toxicol 1990;67:120-2. View abstract.
  339. Peretz A, Neve J, Vertongen F, et al. Selenium status in relation to clinical variables and corticosteroid treatment in rheumatoid arthritis. J Rheumatol 1987;14:1104-7. View abstract.
  340. Smith DK, Feldman EB, Feldman DS. Trace element status in multiple sclerosis. Am J Clin Nutr 1989;50:136-40. View abstract.
  341. Kurekci AE, Alpay F, Tanindi S, et al. Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy. Epilepsia 1995;36:600-4. View abstract.
  342. Ip C. Interaction of vitamin C and selenium supplementation in the modification of mammary carcinogenesis in rats. J Natl Cancer Inst 1986;77:299-303. View abstract.
  343. Sieja K, Talerczyk M. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecol Oncol 2004;93:320-7. View abstract.
  344. Sors TG, Ellis DR, Na GN, et al. Analysis of sulfur and selenium assimilation in Astragalus plants with varying capacities to accumulate selenium. Plant J 2005;42:785-97. View abstract.
  345. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006;98:974-83. View abstract.
  346. Meyer F, Galan P, Douville P, et al. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer 2005;116:182-6. View abstract.
  347. Hercberg S, Galan P, Preziosi P, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004;164:2335-42. View abstract.
  348. Seidner DL, Lashner BA, Brzezinski A, et al. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol 2005;3:358-69. View abstract.
  349. Jordan JM, Fang F, Arab L, et al. Low selenium levels are associated with increased risk for osteoarthritis of the knee. American College of Rheumatology Annual Meeting. San Diego November 12 - 17, 2005. Abstract 1189.
  350. Duffield-Lillico AJ, Dalkin BL, Reid ME, et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 2003;91:608-12. View abstract.
  351. Taylor PR, Parnes HL, Lippman SM. Science peels the onion of selenium effects on prostate carcinogenesis. J Natl Cancer Inst 2004;96:645-7. View abstract.
  352. Li H, Stampfer MJ, Giovannucci EL, et al. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 2004;96:696-703. View abstract.
  353. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 2004;364:1219-28. View abstract.
  354. House WA, Welch RM. Bioavailability of and interactions between zinc and selenium in rats fed wheat grain intrinsically labeled with 65Zn and 75Se. J Nutr 1989;119:916-21. View abstract.
  355. Schrauzer GN. Anticarcinogenic effects of selenium. Cell Mol Life Sci 2000;57:1864-73. View abstract.
  356. Flodin NW. Micronutrient supplements: toxicity and drug interactions. Prog Food Nutr Sci 1990;14:277-331. View abstract.
  357. Venkateswaran V, Fleshner NE, Klotz LH. Synergistic effect of vitamin E and selenium in human prostate cancer cell lines. Prostate Cancer Prostatic Dis 2004;7:54-6. View abstract.
  358. Verrotti A, Basciani F, Trotta D, et al. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res 2002;48:71-5. View abstract.
  359. Fatemi SH, Calabrese JR. Treatment of valproate-induced alopecia (letter). Ann Pharmacother 1995;29;1302. View abstract.
  360. Hurd RW, Van Rinsvelt HA, Wilder BJ, et al. Selenium, zinc, and copper changes with valproic acid: possible relation to drug side effects. Neurology 1984;34:1393-5. View abstract.
  361. Karagas MR, Greenberg ER, Nierenberg D, et al. Risk of squamous cell carcinoma of the skin in relation to plasma selenium, alpha-tocopherol, beta-carotene, and retinol: a nested case-control study. Cancer Epidemiol Biomarkers Prev 1997;6:25-9.. View abstract.
  362. Berger MM, Shenkin A, Revelly JP, et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004;80:410-6. View abstract.
  363. Duffield-Lillico AJ, Slate EH, Reid ME, et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 2003;95:1477-81.. View abstract.
  364. Helzlsouer KJ, Huang HY, Alberg AJ, et al. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 2000;92:2018-23.. View abstract.
  365. Dawson EB, Albers JH, McGanity WJ. The apparent effect of iron supplementation on serum selenium levels in teenage pregnancy. Biol Trace Elem Res 2000;77:209-17.. View abstract.
  366. Reid ME, Duffield-Lillico AJ, Garland L, et al. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 2002;11:1285-91.. View abstract.
  367. Gartner R, Gasnier BC, Dietrich JW, et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 2002;87:1687-91.. View abstract.
  368. Bogye G, Alfthan G, Machay T. Bioavailability of enteral yeast-selenium in preterm infants. Biol Trace Elem Res 1998;65:143-51.. View abstract.
  369. Peretz A, Siderova V, Neve J. Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-controlled trial. Scand J Rheumatol 2001;30:208-12.. View abstract.
  370. Robinson MF, Thomson CD, Jenkinson CP, et al Long-term supplementation with selenate and selenomethionine: urinary excretion by New Zealand women. Br J Nutr 1997;77:551-63.. View abstract.
  371. Van Dael P, Davidsson L, Munoz-Box R, et al. Selenium absorption and retention from a selenite- or selenate-fortified milk-based formula in men measured by a stable-isotope technique. Br J Nutr 2001;85:157-63.. View abstract.
  372. Rao CV, Wang CQ, Simi B, et al. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Cancer Res 2001;61:3647-52.. View abstract.
  373. Hawkes WC, Turek PJ. Effects of dietary selenium on sperm motility in healthy men. J Androl 2001;22:764-72.. View abstract.
  374. Beck MA, Nelson HK, Shi Q, et al. Selenium deficiency increases the pathology of an influenza virus infection. FASEB J 2001;15:1481-3. View abstract.
  375. Navarrete M, Gaudry A, Revel G, et al. Urinary selenium excretion in patients with cervical uterine cancer. Biol Trace Elem Res 2001;79:97-105.. View abstract.
  376. Milde D, Novak O, Stu ka V, et al. Serum levels of selenium, manganese, copper, and iron in colorectal cancer patients. Biol Trace Elem Res 2001;79:107-14.. View abstract.
  377. Berger MM, Reymond MJ, Shenkin A, et al. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med 2001;27:91-100.. View abstract.
  378. Sher L. Role of selenium depletion in the etiopathogenesis of depression in patient with alcoholism. Med Hypotheses 2002;59:330-3.. View abstract.
  379. Finley JW, Ip C, Lisk DJ, et al. Cancer-protective properties of high-selenium broccoli. J Agric Food Chem 2001;49:2679-83.. View abstract.
  380. Duffield-Lillico AJ, Reid ME, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002;11:630-9.. View abstract.
  381. Djujic IS, Jozanov-Stankov ON, Milovac M, et al. Bioavailability and possible benefits of wheat intake naturally enriched with selenium and its products. Biol Trace Elem Res 2000;77:273-85.. View abstract.
  382. Baeten JM, Mostad SB, Hughes MP, et al. Selenium deficiency is associated with shedding of HIV-1--infected cells in the female genital tract. J Acquir Immune Defic Syndr 2001;26:360-4.. View abstract.
  383. Schrauzer GN, Sacher J. Selenium in the maintenance and therapy of HIV-infected patients. Chem Biol Interact 1994;91:199-205.. View abstract.
  384. Combs GF Jr. Selenium in global food systems. Br J Nutr 2001;85:517-47.. View abstract.
  385. Thomson CD, Robinson MF. Urinary and fecal excretions and absorption of a large supplement of selenium: superiority of selenate over selenite. Am J Clin Nutr 1986;44:659-63.. View abstract.
  386. Dias MF, Sousa E, Cabrita S, et al. Chemoprevention of DMBA-induced mammary tumors in rats by a combined regimen of alpha-tocopherol, selenium, and ascorbic Acid. Breast J 2000;6:14-19.. View abstract.
  387. Girodon F, Lombard M, Galan P, et al. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab 1997;41:98-107. View abstract.
  388. Brooks JD, Metter EJ, Chan DW, et al. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 2001;166:2034-8.. View abstract.
  389. Nomura AM, Lee J, Stemmermann GN, Combs GF. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2000;9:883-7.. View abstract.
  390. Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-24.. View abstract.
  391. Shen CL, Song W, Pence BC. Interactions of selenium compounds with other antioxidants in DNA damage and apoptosis in human normal keratinocytes. Cancer Epidemiol Biomarkers Prev 2001;10:385-90. View abstract.
  392. Ustundag Y, Boyacioglu S, Haberal A, et al. Plasma and gastric tissue selenium levels in patients with Helicobacter pylori infection. J Clin Gastroenterol 2001;32:405-8. View abstract.
  393. Zapletal C, Heyne S, Golling M, et al. Influence of selenium therapy on liver microcirculation after warm ischemia/reperfusion: an intravital microscopy study. Transplant Proc 2001;33:974-5. View abstract.
  394. Trafikowska U, Zachara BA, Wiacek M, et al. Selenium supply and glutathione peroxidase activity in breastfed Polish infants. Acta Paediatr 1996;85:1143-5. View abstract.
  395. King JC. Effect of reproduction on the bioavailability of calcium, zinc and selenium. J Nutr 2001;131:1355S-8S. View abstract.
  396. Schrauzer GN. Nutritional selenium supplements: product types, quality, and safety. J Am Coll Nutr 2001;20:1-4. View abstract.
  397. Bogye G, Alfthan G, Machay T, Zubovics L. Enteral yeast-selenium supplementation in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998;78:F225-6. View abstract.
  398. Schrauzer GN. Selenomethionine: a review of its nutritional significance, metabolism and toxicity. J Nutr 2000;130:1653-6. View abstract.
  399. Finley JW, Davis CD, Feng Y. Selenium from high selenium broccoli protects rats from colon cancer. J Nutr 2000;130:2384-9. View abstract.
  400. Shiobara Y, Yoshida T, Suzuki KT. Effects of dietary selenium species on Se concentrations in hair, blood, and urine. Toxicol Appl Pharmacol 1998;152:309-14. View abstract.
  401. Wuyi W, Linsheng Y, Shaofan H, et al. Prevention of endemic arsenism with selenium. Curr Sci 2001;81:1215-8.
  402. Constans J, Delmas-Beauvieux MC, Sergeant C, et al. One-year antioxidant supplementation with beta-carotene or selenium for patients infected with human immunodeficiency virus: a pilot study. Clin Infect Dis 1996;23:654-6. View abstract.
  403. Baum MK, Miguez-Burbano MJ, Campa A, Shor-Posner G. Selenium and interleukins in persons infected with human immunodeficiency virus type 1. J Infect Dis 2000;182 Suppl 1:S69-73. View abstract.
  404. Liu S, Shia D, Liu G, et al. Roles of Se and NO in apoptosis of hepatoma cells. Life Sci 2000;68:603-10. View abstract.
  405. Stewart MS, Spallholz JE, Neldner KH, Pence BC. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 1999;26:42-8. View abstract.
  406. Fleshner NE, Kucuk O. Antioxidant dietary supplements: Rationale and current status as chemopreventive agents for prostate cancer. Urology 2001;57:90-4. View abstract.
  407. El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat Res 2001;475:123-39. View abstract.
  408. Brown BG, Zhao XQ, Chait A. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001;345:1583-93. View abstract.
  409. Kelly P, Musonda R, Kafwembe E, et al. Micronutrient supplementation in the AIDS diarrhea-wasting syndrome in Zambia: a randomized controlled trial. AIDS 1999;13:495-500. View abstract.
  410. Girodon F, Galan P, Monget AL, et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized, controlled trial. MIN. VIT. AOX. geriatric network. Arch Intern Med 1999;159:748-54. View abstract.
  411. Berger MM, Spertini F, Shenkin A, et al. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. Am J Clin Nutr 1998;68:365-71. View abstract.
  412. Wen HY, Davis RL, Shi B, et al. Bioavailability of selenium from veal, chicken, beef, lamb, flounder, tuna, selenomethionine, and sodium selenite assessed in selenium-deficient rats. Biol Trace Elem Res 1997;58:43–53. View abstract.
  413. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000. Available at: http://www.nap.edu/books/0309069351/html/.
  414. Orndahl G, Grimby G, Grimby A, et al. Functional deterioration and selenium-vitamin E treatment in myotonic dystrophy. A placebo-controlled study. J Intern Med 1994;235:205-10. View abstract.
  415. Wang GQ, Dawsey SM, Li JY, et al. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev 1994;3:161-6. View abstract.
  416. Suthutvoravut U, Hathirat P, Sirichakwal P, et al. Vitamin E status, glutathione peroxidase activity and the effect of vitamin E supplementation in children with thalassemia. J Med Assoc Thai 1993;76:146-52. View abstract.
  417. Vinceti M, Rothman KJ, Bergomi KJ, et al. Excess melanoma incidence in a cohort exposed to high levels of environmental selenium. Cancer Epidemiol Biomarkers Prev 1998;7:853-6. View abstract.
  418. Rayman MP. The importance of selenium to human health. Lancet 2000;356:233-41. View abstract.
  419. Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk 1996;3:42-7. View abstract.
  420. Mark SD, Wang W, Fraumeni JF Jr, et al. Do nutritional supplements lower the risk of stroke or hypertension? Epidemiology 1998;9:9-15. View abstract.
  421. Koller LD, Exon JH. The two faces of selenium-deficiency and toxicity--are similar in animals and man. Can J Vet Res 1986;50:297-306. View abstract.
  422. Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 1998;81:730-4. View abstract.
  423. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 1996;276:1957-63. View abstract.
  424. Chan S, Gerson B, Subramaniam S. The role of copper, molybdenum, selenium, and zinc in nutrition and health. Clin Lab Med 1998;18:673-85. View abstract.
  425. Aaseth J, Haugen M, Forre O. Rheumatoid arthritis and metal compounds-perspectives on the role of oxygen radical detoxification. Analyst 1998;123:3-6. View abstract.
  426. Blot WJ, Li JY, Taylor PR. Nutritional intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92. View abstract.
  427. Krizek M, Senft V, Motan J. Influence of hemodialysis on selenium blood levels. Sb Lek 2000;101:241-8.. View abstract.
  428. Neve J. New approaches to assess selenium status and requirement. Nutr Rev 2000;58:363-9.. View abstract.
  429. Arnaud J, Malvy D, Richard MJ, et al. Selenium status in an iodine deficient population of the West Ivory Coast. J Physiol Anthropol Appl Human Sci 2001;20:81-4.. View abstract.
  430. Wasowicz W, Gromadzinska J, Szram K, et al. Selenium, zinc, and copper concentrations in the blood and milk of lactating women. Biol Trace Elem Res 2001;79:221-33.. View abstract.
  431. Hiramatsu T, Imoto M, Koyano T, Umezawa K. Induction of normal phenotypes in ras-transformed cells by damnacanthal from Morinda citrifolia. Cancer Lett 1993;73:161-6. View abstract.
  432. Stein TP, Schluter MD, Leskiw MJ, Boden G. Attenuation of the protein wasting associated with bed rest by branched-chain amino acids. Nutrition 1999;15:656-60. View abstract.
  433. Jie KG, Bots ML, Vermeer C, et al. Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif Tissue Int 1996;59:352-6. View abstract.
  434. Coleman M, Steinberg G, Tippett J, et al. A preliminary study of the effect of pyridoxine administration in a subgroup of hyperkinetic children: A double-blind crossover comparison with methylphenidate. Biol Psych 1979;14:741-51. View abstract.
  435. Baldwa VS, Bhandari CM, Pangaria A, Goyal RK. Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant sources. Ups J Med Sci 1977;82:39-41. View abstract.
  436. Raman A, et al. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine 1996;294.
  437. Srivastava Y, Venkatakrishna-Bhatt H, Verma Y, et al. Antidiabetic and adaptogenic properties of Momordica charantia extract: An experimental and clinical evaluation. Phytother Res 1993;7:285-9.
  438. Leatherdale B, Panesar RK, Singh G, et al. Improvement in glucose tolerance due to Momordica charantia. Br Med J (Clin Res Ed) 1981;282:1823-4. View abstract.
  439. Chevallier A. Encyclopedia of Medicinal Plants. New York, NY: DK Publishing, 1996.
  440. Kung AWC, Pun KK. Bone mineral density in premenopausal women receiving long-term physiological doses of levothyroxine. JAMA 1991;265:2688-91. View abstract.
  441. Golik A, Modai D, Averbukh Z, et al. Zinc metabolism in patients treated with captopril versus enalapril. Metabolism 1990;39:665-7. View abstract.
  442. Golik A, Zaidenstein R, Dishi V, et al. Effects of captopril and enalapril on zinc metabolism in hypertensive patients. J Am Coll Nutr 1998;17:75-8. View abstract.
  443. Adams ME. Hype about glucosamine. Lancet 1999;354:353-4. View abstract.
  444. Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.
  445. Ellenhorn MJ, et al. Ellenhorn's Medical Toxicology: Diagnoses and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams & Wilkins, 1997.
  446. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons, 1996.
  447. United States Pharmacopeial Convention, Inc., ed. Drug Information for the Health Care Professional. 19th ed. Englewood, CO: Micromedex Inc., 1999.
  448. Schulz V, Hansel R, Tyler VE. Rational Phytotherapy: A Physician's Guide to Herbal Medicine. Terry C. Telger, transl. 3rd ed. Berlin, GER: Springer, 1998.
  449. The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.
  450. Foster S, Tyler VE. Tyler's Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies. 3rd ed., Binghamton, NY: Haworth Herbal Press, 1993.
  451. Newall CA, Anderson LA, Philpson JD. Herbal Medicine: A Guide for Healthcare Professionals. London, UK: The Pharmaceutical Press, 1996.
  452. Tyler VE. Herbs of Choice. Binghamton, NY: Pharmaceutical Products Press, 1994.
  453. Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.
  454. Monographs on the medicinal uses of plant drugs. Exeter, UK: European Scientific Co-op Phytother, 1997.
Documento revisado - 02/16/2015